ellen m. lavoie smith, phd, msn, rn, aocn®, faan education
Post on 27-Jan-2022
2 Views
Preview:
TRANSCRIPT
Ellen Lavoie Smith Last Revised 2/27/2020 1
Ellen M. Lavoie Smith, PhD, MSN, RN, AOCN®, FAAN
University of Michigan School of Nursing
Suite 2151; 400 North Ingalls Street
Ann Arbor, MI 48109
734-936-1267
ellenls@med.umich.edu
EDUCATION AND TRAINING
1982 Bachelor of Science in Nursing, University of Vermont, Burlington, VT
1991 Master of Science, Nursing, University of New Hampshire, Durham, NH
1997 Post-graduate Nurse Practitioner Certification, University of New Hampshire,
Durham, NH
2008 PhD, University of Utah, Salt Lake City, UT
CERTIFICATION AND LICENSURE
Vermont RN 026-0026849, 1982 (not renewed as of 2003)
Vermont Adult Nurse Practitioner Licensures in Vermont, 101-0026849, 1982 (not renewed as of 2003)
New Hampshire RN 025381-21, 1993 (not renewed as of 2010)
New Hampshire Adult Nurse Practitioner Licensures 025381-23-05, 1993 (not renewed as of 2010)
Board Certification – Advanced Practice Registered Nurse, 1997
Michigan RN Licensure 4704272442, 2009
Michigan Adult Nurse Practitioner Licensure 470272442, 2009-2016
Advanced Oncology Nurse Certification, 1994-present
ACADEMIC, ADMINISTRATIVE, AND CLINICAL APPOINTMENTS
Academic Appointments
1991-2008 Clinical Instructor, Dartmouth Medical School, Hanover, New Hampshire
2008 Assistant Professor, Dartmouth Medical School, Hanover, New Hampshire
2009- 2015 Assistant Professor, University of Michigan School of Nursing – Division of Acute,
Critical and Long Term Care
2015- PhD Program Director, University of Michigan School of Nursing
2015-2017 Faculty Senate Representative (Elected) - University of Michigan
2015-2019 Associate Professor with Tenure, University of Michigan School of Nursing –
Department of Health Behavior and Biologic Sciences
2016-2018 Chair of the Faculty (Elected), University of Michigan School of Nursing
2018-2021 Executive Committee (Elected), University of Michigan School of Nursing
2018-present Adjunct Associate Professor, Hariri School of Nursing, American University of Beirut
2019, Sept. Professor with Tenure, University of Michigan School of Nursing – Department of
Health Behavior and Biologic Sciences
Hospital/Clinic Appointments
1982-1984 Oncology Staff/ Assistant Head Nurse, Dartmouth-Hitchcock Medical Center,
Hanover, New Hampshire
1984 Oncology Staff Nurse, Intensive Care Leukemia Unit, The Johns Hopkins
Medical Center, Baltimore, Maryland
1984-1986 Oncology Nurse Coordinator, Columbia Medical Plan, Columbia, Maryland
Ellen Lavoie Smith Last Revised 2/27/2020 2
1985-1986 Staff Nurse, Alice Peck Day Memorial Hospital, Lebanon, New Hampshire
1987-2001 Nurse Clinician/Clinical Nurse Specialist/Adult Nurse Practitioner: Thoracic Oncology,
Oncology Infusion Therapy Nurse, Dartmouth-Hitchcock Medical Center, Norris
Cotton Cancer Center, Lebanon, New Hampshire
2001-2009 Director-Advanced Practice Nursing, Department Hematology/Oncology, Dartmouth-
Hitchcock Medical Center, Lebanon, New Hampshire 2007-2009
Director-Clinical Cancer Survivorship Services, Dartmouth-Hitchcock Medical Center,
Norris Cotton Cancer Center, Lebanon, New Hampshire
Other Professional Positions
1992-1997 CALGB Newsletter, Editor of Nursing Section, National Institute of Health-Funded
Cancer and Leukemia Group B (CALGB) Oncology Nursing Committee
1992-2000 Respiratory Core Committee Nurse Liaison, National Institute of Health-Funded Cancer
and Leukemia Group B (CALGB) Oncology Nursing Committee
1997-2000 Vice-Chair, National Institute of Health-Funded Cancer and Leukemia Group B
(CALGB) Oncology Nursing Committee
2000-2011 Chair, National Institutes of Health-Funded Cancer and Leukemia Group B (CALGB)
Oncology Nursing Committee
2011-2012 Co-Chair, National Institutes of Health-Funded Alliance Oncology Nursing Committee
2012- Co-Vice Chair, National Institutes of Health-Funded Alliance Symptom
Intervention Committee
2015 - Co-Chair Hoosier Cancer Research Network Symptom Management Clinical Trial
Working Group
2017- University of Michigan Adult Palliative Medicine Executive Steering Committee
(APMESC) (Elected)
RESEARCH INTERESTS
Neuropathic Pain, Chemotherapy-Induced Peripheral Neuropathy Assessment and Treatment, Pain
Assessment
Dissertation: Smith, E. L. (2008). Clinimetric Properties of Chemotherapy-Induced Peripheral
Neuropathy (CIPN) Measurement Approaches. University of Utah College of Nursing.
GRANTS (LISTED OLDEST TO MOST RECENT)
Active
Principal Investigator
1R01CA235726-01 -- National Cancer Institute
Ellen Lavoie Smith, PhD, APRN, AOCN®, FAAN (PI)
Total Costs: $1,785,811
IDC: $557,833.23
1/1/2019 – 12/31 - 2023
Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced
Peripheral Neuropathy: A Randomized, Double-Bind, Placebo-Controlled Phase II to
Phase III Study
Co-Is: Charles Loprinzi, MD, David Zahrieh, PhD: Co-Is, Mayo Clinic, Rochester, MN
Purpose: The main objective of this Phase II-III study is test to test the efficacy of duloxetine to
prevent oxaliplatin-induced peripheral neuropathy patients with colorectal cancer.
Ellen Lavoie Smith Last Revised 2/27/2020 3
Ellen Lavoie Smith, PhD, ANP-BC, AOCN® (PI)
University of Michigan Cancer Center Health Behavior and
Outcomes Pilot Funding
04/01/2017-2/28/2019
Total Costs: $7,186
In-Kind Support Provided by
Indiana University and Children’s
Hospital and Minnesota
Raymond Hutchinson, MD, Jamie Renbarger, MD., Laura Gilchrist, PhD, PT (Co-I)
A multi-site Pilot Study to Validate the P-CIN (Pediatric Chemotherapy-Induced Neuropathy)
Patient-Reported Outcome Measure
Purpose: To examine the reliability and validity of an electronic pediatric CIPN patient-reported
outcome measure.
Ellen Lavoie Smith, PhD, ANP-BC, AOCN® (PI)
Disarm Therapeutics
07/18/2019-3/31/2021
Direct Costs: $129,792.00 + 56%
Indirect Costs
A natural history study of chemotherapy-induced peripheral neuropathy-EPIPHANY
Purpose: To validate a biomarker of peripheral nerve axon damage following neurotoxic
chemotherapy in patients receiving paclitaxel or vincristine for breast cancer and lymphoma.
Co-Investigator
R01-PAR-18-559
PI: Hsiao-Lan Wang, PhD, University of Southern Florida
Ellen Lavoie Smith, PhD, MSN, RN, AOCN® , FAAN (co-I)
Submitted 2/2019
12/13/2019 – 11/30/2024
Total Costs (DC + IDC): $2,877,273
National Cancer Institute Subcontract Total Costs: $197,176
IDC: $70,781
12/13/2019 – 11/30/2024
Managing Fatigue and Pain Using Personalized Exergame Prescriptions in Head and Neck Cancer
Patients after Their Treatment
Purpose: The test a personalized exergame intervention to improve pain and fatigue following
chemotherapy/radiation treatment for head and neck cancer.
Completed
Principal Investigator
Ellen Lavoie Smith, RN, MS, OCN (PI) 1990
Master’s Thesis Completed without funding
The Role of Individualized and Tape Recorded Patient Educational Sessions on Retention of
Chemotherapy Information in Newly Diagnosed Cancer Patients
Purpose: To test the effect of tape-recorded to non-tape-recorded education on patient knowledge of
chemotherapy side effects and self-management strategies.
Ellen Lavoie Smith, MS, APRN-BC, AOCN (PI) 2004-2007
Oncology Nursing Foundation Total Costs: $44,194
Ellen Lavoie Smith Last Revised 2/27/2020 4
Effects of a Neuropathic Pain Algorithm on Patient and Nursing Outcomes
Co-Is: Louise Meyer, MS, APRN-BC, AOCN, Marie Bakitas, MS, APRN-BC, AOCN, FAAN,
Marilyn Bookbinder, PhD, RN, Peter Homel, PhD., Camilo Fadul, MD
Purpose: To test the effect of a nurse-implemented neuropathic pain evidence-based treatment
algorithm on neuropathic pain severity, and patient function and satisfaction.
Ellen Lavoie Smith, PhD(c), MS, APRN-BC, AOCN (PI) 2006-2007
American Cancer Society Scholarship & Prouty Pilot Funds Total Costs: $66,000
Clinimetric Evaluation of Peripheral Neuropathy Measurement Approaches
Purpose: The purpose of this dissertation research was to test the sensitivity, reliability, and validity
of several measures of chemotherapy-induced peripheral neuropathy.
CTSA Pilot Project
Ellen Lavoie Smith, PhD, APRN-BC, AOCN (PI)
10/2008-10/2009
Dartmouth Center for Clinical and Translational Research Total Costs: $40,000
DMS Study: Assessing the Challenges of New Hampshire’s Cancer Survivors.
Co-Is: Allen Dietrich, MD, Tracy Onega, PhD, Kristen Anton, MS
Purpose: To describe cancer survivors’ physical, psychological, social, spiritual, and sexual function
late effects following cancer treatment.
CALGB 170601
Ellen Lavoie Smith, PhD, MS, APRN-BC, AOCN (PI)
Activation 4/15/2008
Lilly Pharmaceuticals and NCI Division of Cancer
Prevention
Total Costs: Unknown
Peer-Reviewed – R01 Equivalent
Funding via the NCI Cooperative
Group Funding Mechanisms
A Multi-site Phase III Trial of Oral Duloxetine for Treatment of Painful Chemotherapy-Induced
Peripheral Neuropathy - A CALGB National Cooperative Group Study
Co-Is: Camilo Fadul, MD, Tim Ahles, PhD, Stewart Fleishman, MD, Alice Kornblith, PhD, Charles
Shapiro, MD, Electra Paskett, PhD, Herbert Wang, PhD, Connie Cirrincione, MS
Purpose: To asses duloxetine’s effect on peripheral neuropathy-related pain and quality of life.
Ellen Lavoie Smith, PhD, ANP-BC, AOCN® (PI) 03/2013-03/2014
University of Michigan School of Nursing Total Costs: $10,000
Breast Cancer Pain (BCP) - Karen Allen Award and University of Michigan School of Nursing Pilot
Grant
Co-Is: Daniel Clauw, MD, Lynn Henry, MD, PhD, David Williams, PhD, Steven Harte, PhD, Alex
Tsodikov, PhD, Chad Brummett, MD
Purpose: The purpose of this prospective, longitudinal study was to examine whether presence of a
“pain prone” phenotype at diagnosis (prior to definitive surgery) will predict the development of
treatment-related chronic pain in 40 women with clinical stage 0-III breast cancer.
Ellen Lavoie Smith, PhD, ANP-BC, AOCN® (PI)
Genentech
08/-1/2014- 12/31/2016
$123,492
Addressing Quality Cancer Care: Pilot Testing the On Q Care Planning and Symptom Assessment
Ellen Lavoie Smith Last Revised 2/27/2020 5
System
Co-I: James Yang, PhD
Purpose: The goal of this research was to test the On Q Care Planning System (CPS), a novel
computerized system for enhancing symptom assessment and management. The On Q CPS
intervention is designed to improve 1) provider adherence to evidence-based symptom assessment
and management strategies, including those captured by current cancer quality care metrics, and 2)
patient engagement in symptom assessment and management.
Ellen Lavoie Smith, PhD, ANP-BC, AOCN® (PI)
R03 PAR-12-039 - 1R03CA186183-01A1
04/01/2015-03/31/2017
Total Costs: $155,250
National Institutes of Health-National Cancer Institute
Co-Is: James Yang, PhD, Ingemar Merkes, MD, PhD (Co-I)
Chemotherapy-Induced Peripheral Neuropathy (CIPN) Measurement Validation
Purpose: The purpose of this mixed methods psychometric study was to examine the reliability,
validity, and sensitivity of a CIPN patient-reported outcome measure, the EORTC-CIPN20. The main
outcome of this research will be identification of a strong CIPN measurement tool for use in research
and clinical practice settings.
Co-Primary Investigator
Ellen Lavoie Smith, RN, MS, AOCN, Tim Ahles, PhD (PI) 1994
Completed without funding
Dyspnea and Quality of Life in Lung Cancer Patients – 1994
Co-I: Danette Hann, PhD
KL2 - UL1RR024986 Shanley (PI), Smith (PI for Pilot
Study)
07/01/2011-05/30/2013
University of Michigan Clinical Translational Science Award Total Costs: $60,000
Does a Pain Prone Genotype and Phenotype Predict the Development of Chronic Pain Following
Breast Cancer Treatment?
Co-Is: Daniel Clauw, MD, David Flockhart, PhD, MD, PhD, Steven Harte, PhD, Janean Holden,
PhD, RN (Mentors), Norah Lynn Henry, MD, PhD, Chad Brummett, MD (Co-Is)
Purpose: Career development objectives were to learn more about 1) pain genetics and
pharmacogenetics; 2) research designs and methodologies used in genetic and pharmacogenetic
studies; 3) pain physiology, and 4) research designs and methodologies used when exploring CNS
pain mechanisms, to include experimental pain testing methodology. A fifth career development
objective was to reinforce and expand my knowledge regarding the Responsible Conduct of
Research.
Co-Investigator
L. Herbert Maurer, MD (PI) 1992-1997
Clinical Trials in the Rural Community
Co-I: Ellen Lavoie Smith, MS, ARNP, AOCN
Purpose: To describe and address barriers to patient enrollment to cancer clinical trials in rural
Ellen Lavoie Smith Last Revised 2/27/2020 6
settings.
# 10005385-01 Susan L. Beck PhD, APRN, FAAN (PI) 11/1/2007-10/31/2009
Oncology Nursing Foundation Total Costs: $10,845
Does Certification Make a Difference in Pain Outcomes?
Co-I: Patricia Berry PhD, APRN,BC-PCM , William Dudley PhD, Gail Towsley, PhD,
Ellen Lavoie Smith, PhD(c), MS, APRN, AOCN, Jeannine Brant, MS, CNS, AOCN (Co-I)
Purpose: To examine the influence of oncology nursing certification on pain outcomes
Co-I Role: I was the Dartmouth site PI, recruited patients, participated in data collection and analysis,
and collaborated with coauthors to disseminate of the findings.
#58299 Susan Beck, PhD, ARNP, FAAN (PI) 08/15/2006-08/14/2008
Robert Wood Johnson Grant Total Costs: $308,618
Measuring Nursing Care Quality Related to Pain Management
Co-Is: Patricia Berry PhD, APRN,BC-PCM , William Dudley PhD,
Ellen Lavoie Smith, PhD(c), MS, APRN, AOCN, Jeannine Brant, MS, CNS, AOCN
Purpose: The overall aim of this study is to develop and test a robust and parsimonious measure if the
quality of nursing care related to pain management that effectively predicts pain outcomes in
individuals with cancer in the acute-care setting
Co-I Role: I was the Dartmouth site PI, recruited patients, participated in data collection and analysis,
and collaborated with coauthors to disseminate of the findings.
Anantha Shekhar, MD (PI)
NIH Administrative Supplement 3UL 1RR025761-02S5
09/30/2009-09/29/2010
Total Costs: $126,637
Grant to Indiana Clinical and Translational Science Institute (UL1) - Clinical and Genetic Predictors
of Vincristine-Induced Peripheral Neuropathy
Co-Is: Jamie Renbarger, MD, Ellen Lavoie Smith, PhD, APRN-BC, AOCN, Raymond Hutchinson,
MD, Patricia Robertson, MD
Purpose: To assess the psychometric properties of peripheral neuropathy measurement approaches
and the association with genetic predictors.
Co-I Role: I designed and led all aspects of the phenotyping work across four sites. I wrote the aims,
designed the methods, led multi-site training and data collection efforts, and collaborated with the
team to analyze and disseminate the findings.
Daniel Hertz, PharmD, PhD (PI) – University of Michigan 6/1/2014-5/31/15
University of Michigan School of Pharmacy Pilot Grant Total Costs: $33,860
Defining an exposure target for weekly paclitaxel infusion in breast cancer patients
Co-I: Ellen Lavoie Smith, PhD, ANP-BC, AOCN, Norah Lynn Henry, MD, Kelley Kidwell, PhD
Purpose: To demonstrate feasibility of patient enrollment and collection of pharmacokinetic and
longitudinal neuropathy data from breast cancer patients receiving weekly 1-hour paclitaxel infusions
and to assess the preliminary relationship between paclitaxel exposure and neuropathy development.
Co-I Role: I designed the CIPN phenotyping methods using in this study using the Total Neuropathy
Score and the QLQ CIPN-20. I trained and co-supervised the study staff who collected the CIPN
phenotype data, and collaborated with the team to analyze and disseminate the findings.
Ellen Lavoie Smith Last Revised 2/27/2020 7
Lynn, N. Henry, MD, PhD (PI) – University of Michigan 6/1/2015-5/31/16 (approximate)
Damon Runyon-Lilly Clinical Investigator Award from the
Damon Runyon Cancer Research Foundation (#CI-53-10)
Total Costs: Unknown
Pilot Study of an Internet-based Self-Management Program for Symptom Control in Patients with
Early Stage Breast Cancer
Co-Is: Kelley M. Kidwell, PhD, Daniel J. Clauw, MD, Ellen M. L. Smith, PhD, APRN, AOCN,
FAAN, David A. Williams, PhD
Purpose: To determine the effect of an internet-based lifestyle and behavioral self-management
program (PROSPECT) on cancer-related symptoms. I co-designed the intervention, co-authored the
research proposal, and was involved in interpretation and dissemination of the findings.
Co-I Role: I co-designed the intervention, co-authored the research proposal, and was involved in
interpretation and dissemination of the findings.
PAR-08-248 - R01 HD062484: (R01)
Jamie Renbarger, MD – Indiana University (PI)
1/1/2011-12/31/16
Total Costs: $3,555,732
NIH Child Health and Human Development Extramural Research
Pharmacogenetic Determinants of Vincristine Toxicity and Response
Co-Is: Ellen Lavoie Smith, PhD, ANP-BC, AOCN (UM PI), Raymond Hutchinson, MD,
Patricia Robertson, MD (Co-Is)
Purpose: To determine whether candidate gene polymorphisms or other less obvious genetic variants
identified using a genome wide approach are predictive of vincristine neurotoxicity.
Co-I Role: I served in a co-PI capacity for the overall grant and the UM site PI. I co-wrote the grant
and designed and led all aspects of the study related to the vincristine neuropathy measurement aims,
methods, analysis, and dissemination. I was involved in interpretation and dissemination of the
pharmacogenetic findings.
Janean Holden (PI)
University of Michigan MICHR translational research grant
3/2017 – 12/2017
Total Costs: $50,000
Alpha-adrenergic Modulation of Oxaliplatin-Induced Hyperalgesia.
Purpose: To obtain preliminary data regarding the potential effect of Prazocin +/- Duloxetine for the
treatment of oxaliplatin-induced peripheral neuropathy.
Co-Is: Ellen Lavoie Smith & Robert Ploutz-Snyder
Co-I Role: My role was to co-conceptualize the aims, provide consultation regarding oxaliplatin and
duloxetine dosage/route and administration schedule to maximize potential translation of the findings
to human, interpret toxicity patterns, and contribute to the analysis and interpretation of the findings.
The findings served as preliminary data for a submitted R01 (currently under review).
Consultant
1 RC1 CA146882-01: FOA 0D09-003
Jamie Renbarger, MD (PI)
09/30/2009-09/29/2011
Total = $82,681 - 24 months
NIH Challenge in Health & Science Research Recovery Act Limited Competition: NIH Challenge in
Health & Science Research – Developing a Prediction Model for Vincristine-Induced Peripheral
Neuropathy
Co-Is: Ellen Lavoie Smith, PhD, APRN-BC, AOCN (Consultant), Raymond Hutchinson, MD,
Ellen Lavoie Smith Last Revised 2/27/2020 8
Patricia Robertson, MD
Purpose: To develop a prediction model to guide Vincristine dosing based on clinical and genetic
variables.
Consultant Role: I assisted with the interpretation of the neuropathy phenotype data for inclusion in
the prediction model.
Active Training Grants
Ellen Lavoie Smith, PhD, APRN, AOCN®, FAAN (Sponsor)
American Cancer Society Training Grant
7/1/2017-6/30/2019
Total Costs: $30,000
Trainee—Grace Kanzawa-Lee
Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy: A Pilot RCT
Purpose: The purpose of this pilot dissertation study is to examine the effect of a home-based walking
program on chemotherapy-induced peripheral neuropathy severity and outcomes.
Faculty Role: I currently serve as the Faculty PI for this study.
Ellen Lavoie Smith, PhD, ANP-BC, AOCN® (PI) 4/15/2015 -7/31/2018
Robert Wood Johnson Total Costs: $150,000
The purpose of this grant is to fund two predoctoral students enrolled in our PhD Program.
Ellen Lavoie Smith, PhD, ANP-BC, AOCN® (PI) 4/15/2016 -7/31/2019
Robert Wood Johnson Total Costs: $150,000
The purpose of this grant is to fund two predoctoral students enrolled in our PhD Program.
Ellen Lavoie Smith, PhD, ANP-BC, AOCN® (PI) 6/1/2016 -7/31/2018
Jonas Center for Nursing and Veterans Healthcare $30,000
The purpose of this grant is to provide three scholarships to predoctoral students (2 PhD, 1 DNP)
enrolled in our doctoral programs.
Ellen Lavoie Smith, PhD, ANP-BC, AOCN® (PI) 6/1/2019 -7/31/2021
Jonas Center for Nursing and Veterans Healthcare $20,000
Co-I: Lisa Kane-Low, PhD, CNM
The purpose of this grant is to provide two scholarships to predoctoral students (1 PhD, 1 DNP)
enrolled in our doctoral programs.
Completed Training Grants
Ellen Lavoie Smith, PhD, ANP-BC, AOCN (UM Site PI)
BCOG Center for Bio Behavioral Oncology Research and
Training Pilot Grant
7/1/2014-6/30/15
Total Costs: $70,498
Co-Is: Victoria Champion, PhD, RN, Charles Given, PhD, Barbara Given, PhD, RN, David
Haggstrom, MD
Purpose: The mission of the BCOG Center for Bio Behavioral Oncology Research and Training is to
foster a collaborative, interdisciplinary and interuniversity community of researchers, whose goal is
to decrease the burden of cancer through innovative bio /behavioral research, training of our future
Ellen Lavoie Smith Last Revised 2/27/2020 9
researchers, and translation of science to the population.
Co-I Role: I served as the UM site PI for this training grant.
Pending Grant Submissions
Primary Investigator
None pending
Unfunded Grants
Primary Investigator
Ellen Lavoie Smith, PhD, APRN-BC, AOCN (PI) 05/2008-06/2009
NH Department of Health and Human Services $132,000 Awarded
DMS Study: Assessing and Monitoring the Challenges of
Cancer Survivorship and Expanding Capacity for and Access to
Survivorship Services and Palliative Care
Funds rescinded due to budget cuts
Co-Is: Ira Byock, MD, Tracy Onega, PhD, Kristen Anton, MS
Purpose: To describe cancer survivors’ physical, psychological, social, spiritual, and sexual function
late effects over time in patients receiving survivorship and palliative care services.
Amendment to CALGB 170601
Ellen Lavoie Smith, PhD, APRN, AOCN® (PI)
Submission 06/2011, not funded
CALGB Foundation Total Costs: $119,325
CALGB Symptom Intervention Pilot Funds: Pharmacogenetic Predictors of Duloxetine Efficacy
when Used to Treat Painful Chemotherapy-Induced Peripheral Neuropathy
Co-Is: Jamie Renbarger, MD, MS, Todd Skaar, PhD, Debra Barton, PhD, RN, AOCN, FAAN,
Deanna L. Kroetz, PhD, Herbert Pang, PhD, Lydia Hodgson, MS
Purpose: The aim of this exploratory pilot study was to identify associations between duloxetine
response and variability in genes involved in pharmacokinetic and pharmacodynamic pathways and
the neuropathic pain pathway when duloxetine is used to treat taxane or platinum-induced CIPN pain.
R01 PA-10-006
Ellen Lavoie Smith, PhD, APRN, AOCN® (PI)
Resubmission 03/05/2011
Not funded
NIH National Cancer Institute Total Costs: $2,775,868
NIH Mechanisms, Models, Measurement, & Management in Pain Research (R01): Central Nervous
System Mechanisms of Painful Chemotherapy-Induced Peripheral Neuropathy
Co-Is: Daniel Clauw, MD, David Williams, PhD, Steven Harte, PhD, Alex Tsodikov, PhD,
Janean Holden, PhD, RN
Purpose: To examine whether presence of a “pain prone” phenotype at diagnosis (prior to definitive
surgery) will predict the development of treatment-related chronic CIPN pain in women with breast
cancer who received neurotoxic chemotherapy.
First Submission: Impact/Priority Score = 47; Percentile 33; Second Submission: Impact/Priority
Score = 39; Percentile 34
Imbedded Pilot RFA-NR-12-006
Ellen Lavoie Smith, PhD, APRN, AOCN® (PI)
Submission Date 05/16/2012
NIH, National Institute of Nursing Research Not funded
Ellen Lavoie Smith Last Revised 2/27/2020 10
Centers of Excellence in Symptom Science (P30) Pilot Project - Predicting Chronic Neuropathy Pain
in Patients with Multiple Myeloma
Co-Is: Christopher Friese, PhD, RN, AOCN®, Daniel Lebovic
Purpose: To provide preliminary evidence of the presence of a pain prone phenotype, and whether
pain proneness will predict the development of chronic chemotherapy-induced peripheral neuropathy
pain and other somatic symptoms in 40 patients with multiple myeloma receiving neurotoxic
chemotherapy.
Ellen Lavoie Smith, PhD, APRN, AOCN® (PI) Submission Date 01/20/2013
International Association for the Study of Pain (IASP)
Foundation
$20,000
Not funded
IASP Early Career Grant
Co-Is: Daniel Clauw, MD, Lynn Henry, MD, PhD, David Williams, PhD, Steven Harte, PhD,
Alex Tsodikov, PhD, Chad Brummett, MD
Purpose: To examine whether presence of a “pain prone” phenotype at diagnosis (prior to definitive
surgery) will predict the development of treatment-related chronic pain in 40 women with clinical
stage 0-III breast cancer. Received score of 2.7 on 1-5 Scale (1= excellent 2=good, 3=average, 4=fair,
5=poor).
R01 PA-10-006
Ellen Lavoie Smith, PhD, APRN, AOCN® (PI)
First Submission 2/2015
Resubmission 10/2016
Resubmission 6/2017-triaged
NIH National Cancer Institute Total Estimated Costs: $1,928,549.00
NIH Mechanisms, Models, Measurement, & Management in Pain Research (R01): A Placebo-
Controlled RCT Testing a Targeted Multimodal Intervention for Chemotherapy-Induced Peripheral
Neuropathy Pain—the MICH-NP study.
Co-Is: David Williams, PhD, James Yang, PhD
Purpose: To test with duloxetine plus PROSPECT – a self-guided on-line cognitive behavioral
management program—would work better to control painful CIPN than duloxetine alone in patients
with low emotional functioning and receiving oxaliplatin chemotherapy.
First submission - Impact 36 and 25th percentile, Impact 42 and 38th percentile following
resubmission, 3rd submission was triaged.
R21 PA-16-052
Srisuda Ngamkham, PhD, RN (PI)
Ellen Lavoie Smith, PhD, APRN, AOCN® (PI)
First Submission 12/2017
7/1/2018 – 6/30/2020
4/3/18 Review - Triaged
Fogarty International Center Total Costs: $342,379 (IDC
$82,160)
Non-pharmacology Pain Management in Pain Research: Thai Buddhism-based Mindfulness for Pain
Management in Thai Outpatients with Cancer: A Preliminary Study
Co-Is: James Yang, PhD
A RCT trial assessing the effect of a mindfulness meditation and education intervention to control
worse pain in individuals with cancer.
Purpose: To test the effect of a Buddhism-based mindfulness intervention for cancer pain.
Ellen Lavoie Smith Last Revised 2/27/2020 11
Ellen Lavoie Smith, PhD, ANP-BC, AOCN® (PI) 4/15/2019 -7/31/2022
Robert Wood Johnson Total Costs: $150,000
The purpose of this grant is to fund two predoctoral students enrolled in our PhD Program.
OSure – University of Michigan Pilot Grant
Ellen Lavoie Smith, PhD, APRN, AOCN® (PI)
Leah Robinson, PhD (PI)
First Submission 2/1/2018
2nd Submission 4/6/2018
University of Michigan Cancer Center Total Costs: $75,000
Pilot Testing a Movement Intervention for Pediatric Cancer Survivors with Vincristine-Induced
Peripheral Neuropathy
Co-Is: Raymond Hutchinson, MD, Jamie Renbarger, MD, MS
Purpose: The main objective of this pilot study is to describe the incidence, severity, and temporal
patterns of vincristine-induced peripheral neuropathy (VIPN) (e.g., numbness, tingling, and pain in
upper and lower extremities) and associated mobility impairments experienced ≥ one year following
vincristine treatment, and develop and pilot test a movement-based intervention that could ameliorate
vincristine-associated late effects.
Co- Investigator
1 P50 CA244684-01
PI: Friese (contact), Titler, Hawley
Ellen Lavoie Smith, PhD, APRN, AOCN® (co-I/pilot project
PI)
Submitted 2/2019
Total Budget: 9.2 Million
Scored but not funded
National Cancer Institute - Michigan Implementation Science
Center in Cancer Control to Improve Symptom Management
(Michigan IS-C3)
A Pilot Study of NP-rECCovER—An Implementation Strategy to Improve Adoption of Non-Opioid
Treatment in Patients with Cancer-related Neuropathic Pain
Purpose: To describe the feasibility, usability, sustainability, and patient/provider satisfaction
associated with use of NP-rECCovER—a new implementation intervention to improve adoption of
evidence-based neuropathic pain treatment guidelines in patients with cancer.
R01 PA-10-006 Lynn Henry, MD, PhD
NIH National Cancer Institute
Submission Date 02/05/2012
Resubmission 11/05/2012
Not funded
NIH Mechanisms, Models, Measurement, & Management
in Pain Research (R01): Does a pain prone phenotype
predict chronic pain post breast cancer treatment?
Total Costs: $3,599,757
Co-Is: Ellen Lavoie Smith, PhD, APRN, AOCN, Daniel Clauw, MD, David Williams, PhD, Steven
Harte, PhD, Alex Tsodikov, PhD, Chad Brummett, MD
Purpose: To examine whether presence of a “pain prone” phenotype at diagnosis (prior to definitive
surgery) will predict the development of treatment-related chronic pain in 200 women with clinical
stage 0-III breast cancer.
Impact Score 45, Percentile 36
(R01) PA-10-006 Lynn Henry, MD, PhD (PI) Submission Date 02/05/2012
Ellen Lavoie Smith Last Revised 2/27/2020 12
NIH National Cancer Institute, NIH Mechanisms, Models,
Measurement, & Management in Pain Research
First submission scored but not
resubmitted
Chronic Pain in Breast Cancer Survivors: A Mechanism-Based Approach
Co-Is: Ellen Lavoie Smith, PhD, APRN, AOCN, Daniel Clauw, MD, David Williams, PhD,
Steven Harte, PhD, Alex Tsodikov, PhD
Purpose: The overall objective of this research is to determine the differential effects of centrally- and
peripherally-acting analgesics on the best experimental measures of centralized pain: experimental
pain testing and functional neuroimaging. Our ultimate goal was to obtain scientific evidence driving
future research investigating the efficacy of CNS-targeted, individualized pharmacologic and non-
pharmacologic approaches to CIPN pain prevention and treatment.
R01 PA-10-006 Lynn Henry, MD, PhD (PI) Submission Date 10/5/2012
NIH National Cancer Institute Not Scored
NIH Mechanisms, Models, Measurement, & Management in Pain Research (R01): Does a pain prone
phenotype predict response to duloxetine treatment?
Co-Is: Ellen Lavoie Smith, PhD, APRN, AOCN®, Daniel Clauw, MD, David Williams, PhD,
Steven Harte, PhD, Alex Tsodikov, PhD, Chad Brummett, MD (Co-Is)
Purpose: To examine whether presence of a “pain prone” phenotype predicts response to a centrally-
acting agent, duloxetine, as a treatment for chronic pain.
Daniel Hertz (PI)
PA-16-029: Applying Metabolomics to Drive Biomarker
Discovery in Symptom Science (R21)
7/1/2017 – 6/30/2019
Total Costs: $426,250.00
Not Discussed
Metabolomic Profiles Associated with Paclitaxel-Induced Peripheral Neuropathy.
Co-Is: Ellen Lavoie Smith & Kathleen A. Stringer
Purpose: To Identify pre- and post-treatment metabolomic profiles that are associated with paclitaxel-
induced peripheral neuropathy sensitivity
Ellen Lavoie Smith, PhD, APRN, AOCN®, FAAN (Co-PI)
Janean E Holden, PhD, RN, FAAN (Co-PI)
First Submission 5/1/2018
Withdrawn due to lack of cost-share
agreement
The University of Michigan Health System – Peking
University Health Science Center
Joint Institute for Translational and Clinical Research
Total Costs: $100,000
9/1/2018 – 8/31/2020
Chemotherapy-Induced Peripheral Neuropathy (CIPN) Measurement Validation in China
Co-Is: Shaomei Shang, PhD, RN & Dr. Zhiwen Wang, PhD, RN of the Peking University School of
Nursing
Purpose: The main objective of this psychometric study is to test the Chinese version of the EORTC-
QLQ CIPN20 patient-reported outcome measure for CIPN.
Training Grants F31-PA-18-671
Ellen Lavoie Smith, PhD, APRN, AOCN® (PI) First Submission 8/7/18
Scored at 24th percentile, not funded
Ellen Lavoie Smith Last Revised 2/27/2020 13
Clare Donohoe-Pre-Doctoral Candidate nor resubitted
National Cancer Institute - Ruth L. Kirschstein National
Research Service Award (NRSA)
Individual Predoctoral Fellowship (Parent F31)
Total Costs: $116,747.00
Combating the Opioid Epidemic: Can Understanding the Clinical
Phenotype of Adolescents and Young Adults with Sickle Cell Pain Inform Future Non-
Pharmacologic Interventions?
Purpose: The purpose of this longitudinal study is to describe the phenotypic characteristics (i.e.,
physiologic, psychologic, and situational) of adolescents and young adults (14-30) with SCD and
identify which characteristics are predictive of pain severity, pain interference, and increased opioid
consumption within 6 months of baseline phenotyping.
HONORS AND AWARDS
1990 Dartmouth-Hitchcock Medical Center, Student Assistantship in Cancer
Research Award
2004-2008 American Cancer Society - $60,000, Doctoral Scholarship Award
2005 Nursing Spectrum – New England Division, Nursing Excellence Award for Advancing
the Profession
2006 Dartmouth Hitchcock Medical Center, Madelyn R. Smith Promise Award in Nursing
2010 University of Michigan School of Nursing, Visiting Scholar (July and August)
2011 American Academy of Collegiate Nursing, Novice Educator Award Nomination –
Award not received
2012 University of Michigan School of Nursing, Karin Allen Award
2013 University of Michigan School of Nursing, Teacher of the Year
2013 Oncology Nursing Society, New Investigator Award
2014 Midwestern Nursing Research Society, Harriet Werley New Investigator Award
2015 ONS Excellence in Writing Award for Quantitative Nursing Research
2015 & 2018 University of Michigan Honors Student/Mentor Research Award
2018 Fellows of the National Institute of Nursing Research Welch/Woerner Path Paver
Award
MEMBERSHIPS IN PROFESSIONAL SOCIETIES
1984-present Oncology Nursing Society
1991 International Lung Cancer Society
1991 Sigma Theta Tau - International Nursing Honor Society
2006-present Advanced Nursing Research Special Interest Group , Oncology Nursing Society
2010-present American Society of Clinical Oncology
2010-present International Association for the Study of Pain
2011-present Midwest Nursing Research Society
2012-present Pharmacogenomics Research Network (PGRN)
2012-2015 Behavioral Cancer Oncology Group (BCOG)
2015-present American Nurses Association
2016-present Fellow in the American Academy of Nursing
2018-present Peripheral Nerve Society Toxic Neuropathy Special Interest Group
EDITORIAL POSITIONS, BOARDS, AND PEER-REVIEW SERVICE
Ellen Lavoie Smith Last Revised 2/27/2020 14
1992-1997
1992-1999
Cancer and Leukemia Group B (CALGB) Oncology Nursing Committee Newsletter,
Nursing Section; Editor
ONS Nursing Scan in Oncology; Abstractor
2010-present Journal of Cancer Education
2010-present Journal of Pain and Symptom Management
2011-present Breast Cancer Research and Treatment
2011-present European Journal of Oncology Nursing
2013-present Supportive Care Cancer
2013-present Clinical Journal of Oncology Nursing
2013-present European Journal of Cancer Care
2014-present Cancer Nursing
2014-present Oncology Nursing Forum
2017-present Journal of Clinical Oncology
2017-present Cancer
2012-2014 University of Michigan Comprehensive Cancer Center – Protocol Review Committee
2013-2016 Oncology Nursing Society Career Development & Dissertation Award Grant Reviewer
2015-2016 NIH/CSR Cancer Diagnostics and Treatments (CDT) SBIR Study Section
2016-2018 NIH/NCI Provocative Questions Study Section
2016 External Advisory Committee; Michigan Institute for Clinical and Health Research
(MICHR) University of Michigan
2016 National Cancer Institute – Division of Cancer Prevention Clinical Trials Planning
Meeting Participant
2017 The Consortium on Clinical Endpoints and Procedures for Peripheral Neuropathy
Trials (CONCEPPT) of the Analgesic, Anesthetic, and Addiction Clinical Trial
Translations, Innovations, Opportunities and Networks (ACTTION) – Participant and
Presenter
2016-2018 Rackham Doctoral Fellowship Review Committee
2018-present American Society of Clinical Oncology (ASCO) Clinical Guidelines Committee
2018-present University of Michigan Health Sciences and Behavioral Sciences (HSBS) Institutional
Review Board
2018-2019 Oncology Nursing Society Research Priorities Task Force
2019 NIH HEAL Study Section
2019-present FNIR Awards Committee
2020 NIH Nursing and Related Clinical Sciences (NRCS) Study Section
2020 NIH Small Business: Cancer Diagnostics and Treatments (CDT) Study Section (Mail
Reviewer)
TEACHING
Teaching: Advising or Other Formal Role for Undergraduate, Master’s, PhD, DNP, Post-
Doctoral Fellows, or Certificate Projects
Trainee Name Time period
Degree
program
Role:
Title of Project
Terri Voepel-Lewis 2010 Fall PhD-Nursing Academic Advisor
Celia Bridges 2012-2013 PhD-Nursing Academic Advisor
Maureen Berlucchi 2010-Fall MSN, ACNP Academic Advisor
Ellen Lavoie Smith Last Revised 2/27/2020 15
Andrea Engles 2011 Winter MSN, ACNP Academic Advisor
Sasha Murphy 2011 Winter MSN, ACNP Academic Advisor
Kathryn Kovanda 2011 Fall MSN, ACNP Academic Advisor
Kasandra Risch 2011 Fall MSN, ACNP Academic Advisor
Pam Stewart 2011 Fall MSN, ACNP Academic Advisor
Amber Peck 2011 Fall MSN, ACNP Academic Advisor
Kari Durbin 2012 Fall MSN, ACNP Academic Advisor
Stephanie Peterman 2012 Fall MSN, ACNP Academic Advisor
Stephanie Soulia 2012 Fall DNP Academic Advisor
Deborah Thornton 2009-2011 BSN Honor Student Primary Mentor
Karin Thomas 2012-2014 BSN Honors Student Primary Mentor
Kelsey Kippe 2014-2016 BSN Honors Student Primary Mentor
Rylie Haupt 2015-2017 BSN Honors Student Primary Mentor
Zachary Chornoby 2016-2018 BSN Honors Student Co-Primary Mentor
Jenna Swets 2016-2019 BSN Honors Student Primary Mentor
MiJung Jung 2009-2010 MSN-ACNP NURS 699-Reader
Terese Cook 2009-2010 MSN-ACNP NURS 699-Reader
Caralee Smith 2010-2011 MSN-ACNP NURS 699-Advisor
Jesse Moes 2010-2011 PhD-Nursing NURS 699-Reader
Kathryn Evans 2010-2011 MSN-ACNP NURS 699-Reader
Sarah Taylor 2010-2011 MSN-ACNP NURS 699-Reader
Joyce Nancarrow 2011-2012 MSN NURS 699-Reader
Monica Wagner 2012-2013 PhD-Nursing NURS 699-Reader
James Kelly 2012-2013 BS-Pre-Med UROP Sponsor
Malavika Sengupta 2012-2013 Neuroscience UROP Sponsor
Anna Berezovsky 2012-2013 LS & A- Honors UROP Sponsor
Monica Wagner 2013 Spring PhD NURS 797-Independent Study (3 credits)
Celia Bridges 2013 Summer PhD NURS 797-Indepencent Study (2 credit)
Jesse Moes 2010-2012 PhD - Nursing Dissertation Committee Member
Dusty Filliung 2010-2013 PhD - Nursing Dissertation Committee Member
Monica Wagner 2012-2018 PhD-Nursing Dissertation Committee Member
Deborah Lee 2016-20XX PhD-Nursing Michigan State University – Dissertation
Committee Member and Consultant
Noah Zanville 2015-2018 PhD-Nursing Indiana University – F31 Consultant and
Informal Mentor
Terri Voepel-Lewis 2011-2014 PhD-Nursing Dissertation Committee Co-Chair
Robert Knoerl 2013- 2017 BSN-PhD
Hillman Scholar
Dissertation Committee Chair
Grace Kanzawa 2013-20XX BSN-PhD
BSN Honors
Student
Hillman Scholar
Dissertation Committee Chair
Clare Donohue 2015-20XX BSN-PhD
Hillman and T32
Scholar
Dissertation Committee Chair
Ellen Lavoie Smith Last Revised 2/27/2020 16
Katelyn Webster 2018-20XX BSN-PhD T32
Scholar
Dissertation Committee Member
Youmin Cho 2019-20XX PhD Pre-
candidate
Dissertation Committee Chair
Rima Saad 2019-20XX PhD Candidate
American
University of
Beirut
Dissertation Committee Member
Stephanie Soulia 2012 -2018 DNP Project Chair
Nusara Prasertsri, PhD 2015-2016 Post-Doctoral
Fellow
D43 Training Grant Post-Doctoral Fellow
Research Advisor
Srisuda Ngamkham,
PhD
2017 - 2018 Post-Doctoral
Fellow
D43 Training Grant Post-Doctoral Fellow
Research Advisor
Elizabeth Duffy, DNP 2016-present Assistant
Clinical
Professor
Faculty Mentor
Lenette Jones, PhD 2017-2018 Assistant
Professor
Faculty Mentor
Laura Saslow, PhD 2017-2018 Assistant
Professor
Advocate – 3rd Year Review
University of Michigan School of Nursing Teaching Activities
Time period Degree program
Role:
Title of Project
2009-Fall
Term
BSN NURS 357 (2)-Introduction to the Research Approach in
Nursing
2009-Winter
Term
BSN NURS 258 (2)-Assessing the Experience of Health and
Illness-Seminar Faculty-BSN Sophomores
2009-Winter
Term
MSN-ACNP NURS 506-Oncology Clinical Lecture
2009-2011 Fall
Terms
MSN-ACNP NURS 502-Oncology Pathophysiology Lecture
2010-Fall
Term
BSN NURS 495-Smith Program of Research Lecture
2010-Fall
Term
BSN NURS 254-Pain Management Lecture
2010-Fall
Term
BSN NURS 257 (3)-Introduction to the Research Approach in
Nursing (61 Students)
2010-Fall
Term
MSN-ACNP NURS 532-Pain Theory Lecture
2011-Winter
Term
BSN NURS 257 (6)-Introduction to the Research Approach in
Nursing (210 Students)
2011-Fall PhD NURS 869-Smith Program of Research Lecture
2012 Fall
2013 Winter
2014 Winter
Second Career NURS 536-Guest Lecture-CALGB 170601-A Randomized
Controlled Trial
Ellen Lavoie Smith Last Revised 2/27/2020 17
2015 Winter
2012, 2013
Winter Term
BSN NURS 257 (3)-Introduction to the Research Approach in
Nursing (133 Students)
2013 Fall BSN NURS 245-Pathophysiology-Co-faculty
2013 Fall
2014 Fall
Undergrads& graduate
students from multiple
disciplines
NURS 502-Cancer Course-Pain Lecture – Recorded Lecture
2013 & 2014
Fall
PhD NURS 869-Theoretical Underpinnings Guiding My Program
of Research Lecture
2014 Winter BSN NURS 395-(2)-Honors Seminar
2014 Winter BSN NURS 257 (3)-Introduction to the Research Approach in
Nursing (144 students)
2014 Fall BSN NURS 245-Pathophysiology- Co-faculty
2015 Winter BSN NURS 395-Honors Seminar
2015 Winter BSN NURS 257 (3)-Introduction to the Research Approach in
Nursing (164 students)
2016 Winter BSN NURS 395 (2)-Honors Seminar
2015-2018 Fall PhD NURS 890 (3)-Substantive Research Focus I
2016-2019
Winter
PhD NURS 891 (3)-Substantive Research Focus II
Outside the University of Michigan
Dartmouth Medical School
Time period Role
2008-July Cancer Survivorship Component of Hematology/Oncology DMS Elective for 4th Year
Medical Students
Dartmouth-Hitchcock Medical Center
Time period Role
1982-present Numerous lectures to health-care professionals (see invited presentations)
1982-present Informal clinical teaching to medical students, housestaff, and nursing students
Regional
Time period Role
2006 Preceptor High School Honors Student-Dartmouth Research Practicum
2006-Fall Adjunct Professor Colby-Sawyer College-Medical Surgical Nursing Course
1991 Nurse Preceptor for Undergraduate and Graduate Students: University of New
Hampshire, Norwich University, University of Vermont, MGH Institute of Health
Professions
COMMITTEE, ORGANIZATIONAL, AND VOLUNTEER SERVICE
Institutional
1989 Dartmouth-Hitchcock Medical Center, Safe Handling Task Force, Committee Member
1989-2009 Dartmouth-Hitchcock Medical Center, Oncology Chemotherapy/Mini-Course
Curriculum Planning Committee, Committee Member
Ellen Lavoie Smith Last Revised 2/27/2020 18
1992 Dartmouth-Hitchcock Medical Center, Thoracic Oncology Strategic Planning
Committee, Committee Member
1992 Dartmouth-Hitchcock Medical Center, Survivorship Committee, Committee Member
1992-1995 Dartmouth-Hitchcock Medical Center, Great American Smoke Out - American Cancer
Society, Chair
1992-2000 Dartmouth-Hitchcock Medical Center, Oncology Patient Education Committee, Chair
1994-1995 Dartmouth-Hitchcock Medical Center, Cancer Clinical Review Committee, Committee
Member
1995-2000 Dartmouth-Hitchcock Medical Center, Patient Resource Center Committee, Committee
Member and Chair
1999-2000 Dartmouth-Hitchcock Medical Center, Mid-Level Provider Task Force, Committee
Member
2006 Dartmouth-Hitchcock Medical Center, Chair Inpatient Service Consultation Quality
Improvement Group, Committee Member
2006 Dartmouth-Hitchcock Medical Center, Survivorship Clinic Planning Committee, Chair
2006 Dartmouth-Hitchcock Medical Center, APN RVU Subcommittee, Chair
2008 Dartmouth-Hitchcock Medical Center, Getting to Yes – Inpatient Access Committee,
Committee Member
2008 Dartmouth-Hitchcock Medical Center, Nursing Research Taskforce, Committee Member
2009, 2010 University of Michigan School of Nursing, MNRS Student Abstract Submissions
Reviewer, Abstract Reviewer
2009, 2010, University of Michigan School of Nursing, Dean’s Research Day, Abstract Reviewer
2013
2009-2012 University of Michigan Health Systems/School of Nursing, UMHS/SON Nurse Research
Partner Committee, Member & Abstract Review Chair
2009-present University of Michigan School of Nursing, Cancer Center Member, Member
2010 University of Michigan School of Nursing, Faculty Development Task Force, Member
2010-2011 University of Michigan School of Nursing, LEO Major Review Committee, Member
2010-2011 University of Michigan School of Nursing, Committee on Academic Admissions and
Scholarly Standing (CAASS), Member
2011 University of Michigan – Provost-Invited, Classroom Technology Focus Group, Member
2011 Visiting Students & Faculty: Chiba University, Japan, International
Collaboration/Advisement, Consultant/Host
2011-2012 University of Michigan School of Nursing, Technology Advisory Committee, Member
2011-2013 University of Michigan School of Nursing – Division 1, Social Committee, Member
2011-2013 University of Michigan School of Nursing, DNP Advisory Committee, Member
2011-present University of Michigan School of Nursing, New Building: Research & Classroom
Subcommittees, Member
2012-2013 University of Michigan School of Nursing, Dean’s Research Day Planning Committee,
Vice-Chair
2012-2015 University of Michigan Cancer Center, Protocol Review Committee – Cancer Center,
Member
2013-2014 University of Michigan School of Nursing, Dean’s Research Day Planning Committee,
Chair
2013-2014 University of Michigan Health System, Clinical Trials Workflow Committee, Member
2013-2014 University of Michigan Health System, Pain and Comfort Committee, Member
Ellen Lavoie Smith Last Revised 2/27/2020 19
2013-2014 University of Michigan School of Nursing, Division I Advisory Committee, Member
2013-2014 University of Michigan School of Nursing, Teaching/Learning Technology Task Force,
Member
2013-2014 University of Michigan School of Nursing, Dean’s Research Day Planning Committee,
Chair
2014-2017 University of Michigan Faculty Senate Member
2014-2015 University of Michigan Department 1 Faculty Search Committee Chair
2015-2017 CAASS Ex-Officio Member
2015-2017 Curriculum Committee Ex-Officio Member
2016-2017 University of Michigan Department Oncology Faculty Search Committee Member
2018-2020 University of Michigan Palliative Care Steering Committee
2019 Productivity Task Force: University of Michigan School of Nursing
2020 Civility and Student Evaluations Task Force: University of Michigan School of Nursing
Regional
2007-2009 State of New Hampshire Department of Health and Human Services, Cancer
Survivorship Subcommittee, Committee Member
National
1991-2000 National Cancer Institute, Patient Education Committee, Member
1992-2000 National Institute of Health-Funded Cancer and Leukemia Group B (CALGB) Oncology
Nursing Committee, Respiratory Core Committee Nurse Liaison
1997-2000 National Institute of Health-Funded Cancer and Leukemia Group B (CALGB) Oncology
Nursing Committee, Vice-Chair
2000-2011 National Institutes of Health-Funded Cancer and Leukemia Group B (CALGB) Oncology
Nursing Committee, Chair
2003-2004 Oncology Nursing Society, Evidence Based Practice Subgroup of the Research Advisory
Committee, Member
2003 Oncology Nursing Society, Research Advisory Panel: Evidence-Based Practice
Subgroup, Committee Member
2006 Oncology Nursing Society, Cooperative Group Nursing Research Training Program,
Curriculum Planning Committee-Program Moderator
2008 National Institute of Health, State of the Science Committee Focused on Chemotherapy-
Induced Peripheral Neuropathy, Member
2011 National Institute of Health – National Cancer Institute Symptom Management and
Quality of Life Steering Committee, Chemotherapy-Induced Peripheral Neuropathy
Working Group, Member
2011-2012 National Institutes of Health-Funded Alliance Oncology Nursing Committee, Co-Chair
2012 National Institute of Health – National Cancer Institute Symptom Management and
Quality of Life Steering Committee, Symptom Management and Quality of Life Steering
Committee (SxQOL SC), Ad Hoc, Reviewer
2012- National Institutes of Health-Funded Alliance Symptom Intervention Committee, Co-
Vice Chair
2013 Oncology Nursing Society, Chemotherapy-Induced Peripheral Neuropathy Survey
Project Team, Chair
Ellen Lavoie Smith Last Revised 2/27/2020 20
2013 American Society of Clinical Oncology, Neuropathy in Cancer Patients Clinical
Guideline Committee, Member
2013 National Institutes of Health-Funded Alliance Symptom Intervention Committee,
Chemotherapy-Induced Peripheral Neuropathy Working Group, Member
2018-2022 American Society of Clinical Oncology (ASCO) Survivorship Guideline Advisory Group
2019-present Disarm Therapeutics Advisory Board
2019-present Peripheral Nerve Society Toxic Neuropathy Board of Directors
International
2014-2015 MichiKen Teaching and Service Trip – Meru, Kenya, Africa: Consulted with nurse and
physician leaders at Consolata Hospital regarding approaches to enhance translation of
research evidence into practice and the provision of oncology services to rural Kenyans
CONSULTING POSITIONS
2002 Advisor/Consultant, Lilly Pharmaceuticals
2005 Advisor/Consultant, Bristol-Myers Squibb
2011 Advisor/Consultant, Millennium Pharmaceuticals
2013-2014 On Q Health Consultant
2014-2015 Consolata Hospital, Meru, Kenya, Africa
2016 El Camino Hospital Cancer Center, Mountain View, CA – CIPN Assessment QI Project
2017 American Society of Clinical Oncology (ASCO): Grant Writing
2017 Mundipharma Research, Cambridge, England
2018 Windrose Consultant Group, London, England
2018 Diana Martinez, MD, Columbia University, New York, NY
2018-present University of Southern Florida
2018-present Disarm Pharmaceuticals
2018-present Asahi Kasei Pharma Corporation
VISITING PROFESSORSHIPS, SEMINARS, AND EXTRAMURAL INVITED
PRESENTATIONS
Regional Invited Presentations
1983 Autologous Bone Marrow Transplantation: Constipation Management - Nursing Grand
Rounds, Dartmouth-Hitchcock Medical Center, Hanover, NH
1987 Breast Cancer Chemotherapy, Dartmouth-Hitchcock Medical Center, Hanover, NH
1988-1999 Biannually, Nursing Care of the Patient Receiving Cancer Chemotherapy, Dartmouth-
Hitchcock Medical Center, Lebanon, NH
1990-2002 Biannually, Oncology Core Class: Lung Cancer: Diagnosis, Treatment, and A Case
Approach to Related Oncologic Emergencies, Dartmouth-Hitchcock Medical Center,
Lebanon, NH
05/1991 Nursing Care of the Patient Receiving Cancer Chemotherapy, Saint Anselem's College,
Manchester, NH
05/1991 Lung Cancer Educational Series, Dartmouth-Hitchcock Medical Center, Lebanon, NH
05/1991 Lung Cancer Educational Series: Public Lectures. Dartmouth-Hitchcock Medical
Center, Lebanon, NH
05/1991 Cancer Patient Education: Nursing Grand Rounds, Dartmouth-Hitchcock Medical
Center, Lebanon, NH
Ellen Lavoie Smith Last Revised 2/27/2020 21
03/1992 Dyspnea and Quality of Life, Veterans Administration Hospital,
White River Junction, VT
11/1992 Clinical Trials in the Rural Community: The Nursing Role, Dartmouth-Hitchcock
Medical Center, Lebanon, NH
05/1997 Chemotherapy Highlights for Primary Care Providers, Dartmouth-Hitchcock Medical
Center, Lebanon, NH
10/1997 Clinical Trials in Rural Populations: Nurse Executive Meeting, Dartmouth-Hitchcock
Medical Center, Lebanon, NH
11/1997 Dyspnea and Quality of Life of Patients with Lung Cancer: Irene Bradley Parker
Conference, Dartmouth-Hitchcock Medical Center, Lebanon, NH
11/1997 Dyspnea and Quality of Life of Patients with Lung Cancer/Dyspnea Management for
Nurses, Oncology Nursing Society Chapter, Lebanon, NH
1998 What Visiting Nurses Need to Know about Chemotherapy Side Effects, Visiting Nurse
Association, West Lebanon, NH
07/1999 How to Place Patients on Clinical Trials Role Play, Dartmouth-Hitchcock Medical
Center, Lebanon, NH
08/1999, Sleep Disturbances - Prostate Cancer Support Group, Dartmouth-Hitchcock Medical
Center, Lebanon, NH
09/1999 Oncology for Community Nurses, Vermont Technical College, Montpelier, VT
10/1999 Oncology Jeopardy for Outreach Oncology Nurses, Dartmouth-Hitchcock Medical
Center, Lebanon, NH
1999-2003 Biannually, Chemotherapy Jeopardy, Dartmouth-Hitchcock Medical Center,
Lebanon, NH
03/2000 Lung Cancer: Diagnosis, Treatment, and Symptom Management, Oncology Nursing
Society Chapter, Dover, NH
03/2000 Sleep Disturbances – Brain Tumor Support Group, Dartmouth-Hitchcock Medical
Center, Lebanon, NH
09/2002, Oncology Core Class: Metabolic Emergencies, Dartmouth-Hitchcock Medical
2003, 2004 Center, Lebanon, NH
09/2003 Glutamine for the Treatment of Peripheral Neuropathy, Advanced Practice
Nursing Retreat, Portsmouth, NH
08/2005 Assessment and Treatment of Neuropathic Pain, New Hampshire Nurses Association,
Portsmouth, NH
11/15/2006 Great Issues in Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH
06/01/2007 A Decade of Interdisciplinary Collaboration to Understand, Measure, and Treat
Chemotherapy-Induced Peripheral Neuropathy (CIPN) – Hematology/Oncology- Norris
Cotton Cancer Center Ground Rounds, Dartmouth-Hitchcock Medical Center,
Lebanon, NH
10/2007 Malignancy-Related Peripheral Neuropathy - Hematology/Oncology Mini-Course,
Dartmouth-Hitchcock Medical Center, Lebanon, NH
10/2007 Superior Vena Cava Syndrome Hematology/Oncology Mini-Course,
Dartmouth-Hitchcock Medical Center, Lebanon, NH
10/12/2007 Peripheral Neuropathy Measurement Approaches, North Eastern Clinical Oncology
Society, Burlington, VT
02/15/2008 Clinimetric Properties of Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Ellen Lavoie Smith Last Revised 2/27/2020 22
Measurement Approaches: 22nd Annual Neuroscience Day, Dartmouth College,
Hanover, NH
03/15/2008 Developing a Cancer Survivorship Program, St. Joseph’s Hospital Survivorship
Committee, Center Harbor, NH
03/29/2008 Nurse Measurement of Chemotherapy-Induced Peripheral Neuropathy (CIPN) and
Associated, NH Chapter Oncology Nursing Society, Lebanon, NH
04/01/2008 Assessment Chemotherapy-Induced Peripheral Neuropathy (CIPN): Which Measurement
Approaches are Best: Nursing Grand Rounds, Dartmouth-Hitchcock Medical Center,
Lebanon, NH
04/21/2009 Inch-by-Inch . . or is it Row by Row?, The Complexities of Measurement Science,
Dartmouth College Journal Club, Lebanon, NH
06/19/2009 Measuring the Quality of Nursing Care Related to Pain Management, Dartmouth-
Hitchcock Medical Center, Lebanon, NH
09/30/2009 Chemotherapy-Induced Peripheral Neuropathy and Associated Pain: Past, Present, &
Future Research Directions, University of Michigan Oncology Quality of Life Group,
Ann Arbor, MI
11/25/2009 The ADVANCE Trial: A Multicenter Validation Study of Biomarkers of Vincristine
Peripheral Neuropathy in Children with Acute Lymphoblastic Leukemia, University of
Michigan –MCRU (Michigan Clinical Research Unit), Ann Arbor, MI
03/01/2010 The ADVANCE Trial: A Multicenter Validation Study of Biomarkers of Vincristine
Peripheral Neuropathy in Children with Acute Lymphoblastic Leukemia, University of
Michigan –MCRU (Michigan Clinical Research Unit), Ann Arbor, MI
09/06/2012 Chronic Pain Across Populations, University of Michigan Nursing Grand Rounds,
Ann Arbor, MI
01/17/2013 Chronic Pain Across Populations, University of Michigan Nursing Leadership
Conference, Ann Arbor, MI
03/30/2015 Uncovering the Mysteries of Chronic Pain in Cancer Populations, University of Michigan
School of Nursing Dean’s Research Day, Ann Arbor, MI
3/17/2016 Midwestern Nursing Research Conference Symposium: Cancer Treatment-Related Pain
and Peripheral Neuropathy: Mechanisms, Measurement and Management - The
reliability, validity, and sensitivity of the European Organization for Research and
Treatment of Cancer (EORTC) Quality of Life Questionnaire-chemotherapy-induced
Peripheral Neuropathy (QLQ-CIPN-20).
3/22/18 Bedside to Bench to Bedside: Managing Painful Chemotherapy-Induced Chronic Pain,
University of Michigan/Michigan Medicine Palliative Care Research Conference
National Invited Presentations
05/1992 Self -Care Research, Oncology Nursing Society Congress, San Diego, CA
11/1992 Nursing Research Within CALGB, CALGB, Saint Louis, MO
05/1993 Dyspnea: Symptom Management and Life Quality, Oncology Nursing Society
Local Chapter, Boston, MA
05/1993 Nursing Research within CALGB, CALGB, Baltimore, MD
05/05/1994 Communicating Options Throughout The Lung Cancer Experience, Oncology Nursing
Society Annual Congress, Cincinnati, OH
05/06/1994 Overview of Non-Small-Cell Lung Cancer, Oncology Nursing Society Annual Congress,
Cincinnati, OH
03/12/1995 Dyspnea Management, Oncology Nursing Society Local Chapter, Stowe, VT
Ellen Lavoie Smith Last Revised 2/27/2020 23
05/1996 Dyspnea and Quality of Life, CALGB, Miami, FL
10/1996 Patient Education Improvement Efforts at a Comprehensive Cancer Center, American
Association of Cancer Education, Chicago, IL
05/1998 Sleep Disturbances, Oncology Nursing Society Annual Congress, San Francisco, CA
05/2000 A Multidisciplinary Quality Improvement Approach to Improve Neuropathic
Pain Management in Cancer Patients, Oncology Nursing Society Annual Congress,
San Antonio, TX
06/2000 Lung Cancer: Diagnosis, Treatment, and Symptom Management, Pharmaceutical,
Boston, MA
06/2000 Lung Cancer: Diagnosis, Treatment, and Symptom Management, Pharmaceutical,
Peabody, MA
04/2001 Chemotherapy-Induced Peripheral Neuropathy: Assessment and Treatment,
Oncology Nursing Society Chapter, Burlington, VT
05/2001 CPT-11 and Lung Cancer, Pharmaceutical, Las Vegas, NV
02/04/2002, Chemotherapy-Induced Peripheral Neuropathy: Assessment and Treatment
11/25/2002 Strategies to Improve Patient Quality of Life, Pharmaceutical, National Teleconference
05/2002 Chemotherapy-Induced Peripheral Neuropathy: Assessment and Treatment,
Oncology Nursing Society Chapter, Albany, NY
06/2002 Cooperative Group Nursing Research Summit, CALGB, Washington, DC
06/2002 Chemotherapy-Induced Peripheral Neuropathy: Assessment and Treatment,
Oncology Nursing Society Chapter, Lowell, MA
11/2002 Glutamine for the Treatment of Peripheral Neuropathy, CALGB, Chicago, IL
12/2009- The Influence of Central and Peripheral Nervous System Side Effects on Cancer
10/2003 Therapy: A Patient-Focused Model for Change, Pharmaceutical,
National Teleconference
11/2004 Peripheral Neuropathy Measurement Approaches, CALGB, Atlanta, GA
12/13/2005 Multidisciplinary Care of Squamous Cell Carcinoma of the Head & Neck,
Pharmaceutical, Orlando, FL
05/2006 Evidence-Based Practice for Breast & Lung Cancer, Oncology Nursing Society Annual
Congress, Boston, MA
06/16/2006 A Celebration of CALGB Oncology Nursing, CALGB, Chicago, IL
10/19/2006 Cooperative Group Values, Mission, Aims, and Group Infrastructure –Multi-site Training
Program, Oncology Nursing Society, Washington, DC
02/10/2007 Frontiers of Research, Oncology Nursing Society Research Meeting, Hollywood, CA
9/14/2007 Developing a Cancer Survivorship Program, Florida Cancer Conference,
Palm Beach, FL
03/10/2008 Clinimetric Properties of Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Measurement Approaches, University of Massachusetts, Boston, MA
04/03/2008 Clinimetric Properties of Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Measurement Approaches, University of Utah, Salt Lake City, UT
04/30/2008 Clinimetric Properties of Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Measurement Approaches, University of Michigan, Ann Arbor, MI
11/04/2008 Clinimetric Properties of Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Measurement Approaches, University of Indiana, Indianapolis, IN
5/12/2009 The CARES Program: Cancer & Related Events Survivor Program; The Path to Program
Development, Hartford Hospital20th Annual Mary Mulready Sullivan
Ellen Lavoie Smith Last Revised 2/27/2020 24
Oncology Symposium, Harford, CT
09/29/2009 Nursing Management of Cancer Treatment-Induced Peripheral Neuropathy: A Quality
Improvement Initiative, Rochester Oncology Clinic, Rochester, NY
11/30/2009 Nursing Management of Cancer Treatment-Induced Peripheral Neuropathy: A Quality
Improvement Initiative, Catholic Medical Center Oncology Nursing Society Chapter,
Bedford, NH
11/13/2010 New Perspectives in Oncology Practice - Peripheral Neuropathy Management, Reed
Medical Education, New York, NY
05/12/2011 Chemotherapy-Induced Peripheral Neuropathy – Implications for Nurses, North Central
Cancer Oncology Group, Mayo Clinic- Rochester, MN
06/25/2011 Chemotherapy-Induced Peripheral Neuropathy Measurement: Implications for
Cooperative Group Research, CALGB – Pharmacology Experimental Therapeutics
Committee, Boston, MA
10/08/2011 Chemotherapy-Induced Peripheral Neuropathy, ONS Survivor Series, Detroit, MI
11/13/2011 Chemotherapy-Induced Peripheral Neuropathy Measurement: Implications for
Cooperative Group Research, ECOG – Pharmacogenetic Committee, Ft. Lauderdale, FL
06/05/2012 ASCO Scientific Symposium Presentation: CALGB 170601: Results of a RCT Testing
Duloxetine for CIPN Pain, American Society of Clinical Oncology, Chicago, IL
06/29/2012 CALGB 170601: Results of a RCT Testing Duloxetine for CIPN Pain, The Alliance,
Chicago, IL
09/19/2012 CALGB 170601: Results, Successes, and Future Recommendations, NIH Symptom &
Quality of Life Steering Committee, Bethesda, MD
09/29/2012 Prevention and Management of Peripheral Neuropathy, ONS Hematology Regional
Conference, Indianapolis, IN
10/27/2012 Treatment of Chemotherapy-Induced Peripheral Neuropathy, Supportive Oncology
Conference, Chicago, IL
11/18/2012 Measuring Vincristine-Induced Neuropathy in Children (Research Podium), ONS
Connections Conference, Phoenix, AZ
12/09/2012 Invited Lecture: CALGB 170601: Results of a RCT Testing Duloxetine for CIPN Pain,
American Society of Hematology, Atlanta, GA
06/24/2013 Chronic Pain Across Populations, Rochester, NY Cancer Center, Rochester, NY
11/08/2013 Victoria Mock New Investigator Award Lecture, Oncology Nursing Society, Dallas, TX
03/21/2014 Cancer Treatment-Related Chronic Pain: Assessment, Treatment, and Prediction, Illinois
Medical Association, Chicago, IL
04/10/2014 Nurturing Excellence Through Nursing Research 2014, Ohio State University,
Columbus, OH
03/1/2017 NIH Symptom and Quality of Life Steering Committee: Invited CIPN Research Panelist
03/23/17 Analgesic, Anesthetic, and Addition Clinical Trial Translations, Innovations,
Opportunities and Networks: Invited CIPN Research Panelist
4/8-9/2019 Oncology Nursing Society Research Intensive Faculty, Anaheim California
3/10-13/2019 Visiting Professor – University of Southern Florida - Managing Painful Chemotherapy-
Induced Chronic Pain: Bedside to Bench to Bedside, University of Southern Florida
5/10/2019 Alliance Group Meeting - Managing Painful Chemotherapy-Induced Chronic Pain:
Bedside to Bench to Bedside, Chicago, IL
International Invited Presentations
Ellen Lavoie Smith Last Revised 2/27/2020 25
08/1997 Dyspnea and Quality of Life, International Association for the Study of Lung Cancer;
Dublin, Ireland
07/2015 Chronic Pain Across Non-Communicable Disease Populations; Korat, Thailand
07/2015 IMMPACT Guided Approaches to Designing Chronic Pain Studies; Korat, Thailand
6/23/2016 Using Interdisciplinary Teams to Facilitate Research and Clinical Practice; Chiang Mai,
Thailand
6/24/2016 Putting Science into Teams – Keynote Lecture in Collaboration with Dean Kathleen
Potempa: Chiang Mai, Thailand
11/4/16 On Pins & Needles: VIPN Assessment, Characteristics and Patterns in Children with
Leukemia: POGO, Toronto, Canada
6/28/2018 Chemotherapy-Induced Peripheral Neuropathy Measurement Science: Vienna, Austria,
Multinational Association of Supportive Care in Cancer (MASCC) Conference
2/2019 Invited Lecture: Chemotherapy-Induced Peripheral Neuropathy and Associated Pain
Management – Bedside to Bench to Bedside - 4th International Conference on Prevention
and Management of Chronic Conditions – Bangkok, Thailand
BIBLIOGRAPHY
(aPeer Reviewed; bData-based; c BioMed Libraries designated all-time top 10 article published in my
domain, dSenior Author, eco-published with student or post-doctoral fellow)
Journals and Publications
1. Smith, E. L. (1992). Dyspnea and Quality of Life. In M. B. Whedon, & L. L. Powel (Eds.),
Quality of life: A nursing challenge, Physical Well-Being, 1(1):31-38.
2. Smith, E. L. (1998). Pulmonary Metastasis. In P. J. Haylock (Ed), Nursing Implications in the
Management of Patients with Metastatic Disease, Seminars in Oncology Nursing, 14(3), 178-186.
PMID: 9718643.
3. a,bMaurer, L. H., Davis, T., Hammond S., Smith, E., West, P., & Doolittle, M. (2001). Clinical
trials in a rural population: Professional Education Aspects. Journal of Cancer Education, 16(2),
89-92. PMID: 11440069.
4. a,bSmith, E. L., Hann, D. M., Ahles, T. A., Furstenberg, C. T., Mitchell, T. A., Meyer, L., Maurer,
L. H., Rigas, J., & Hammond, S. (2001). Dyspnea, Anxiety, Body Consciousness, and Quality of
Life of Patients with Lung Cancer. Journal of Pain and Symptom Management, 21(4), 323-328.
PMID: 11312047.
5. a,bSmith, E. L., Whedon, M., Bookbinder, M. (2002) Quality Improvement Approach of Painful
Peripheral Neuropathy. Seminars in Oncology Nursing, 18(1), 36-43. PMID: 11878038.
6. aSmith, E.L., Skosey, C, Armer, J., Berg, D., Cirrincione, C., & Henggeler, M. (2006). The
Cancer and Leukemia Group B Oncology Nursing Committee (1983-2006): A History of Passion,
Commitment, Challenge, and Accomplishment. Clinical Cancer Research, 12(11), 3638s-3641s.
PMID: 16740799.
7. aSmith, E. L., Beck, S. L., & Cohen, J. A. (2008). The Total Neuropathy Score (TNS): A Tool for
Use by Oncology Nurses When Measuring Chemotherapy-Induced Peripheral Neuropathy.
Oncology Nursing Forum, 35 (1), 96-102. PubMed PMID: 18192158.
8. a,d Schaal, A. D., Skalla, K. A., Mulrooney, T. J., Stearns, D., & Smith, E. M. L. (2008). Building a
collaboration of hematology-oncology advanced practice nurses. Part II: Outcomes. Oncology
Nursing Forum, 35, (6), 875-878. PMID: 18980918.
Ellen Lavoie Smith Last Revised 2/27/2020 26
9. a,bSmith, E. L., Bakitas, M., Homel, P., Fadul, C., Skalla, K., Meyer, L., & Bookbinder, M. (2009).
Using Quality Improvement Methodology to Improve Neuropathic Pain Screening and Assessment
in Patients with Cancer. Journal of Cancer Education, 24(2), 135-140. PMID: 19431031.
(November 26, 2012 - 2nd most downloaded article in the Journal’s history)
10. *a,b,cSmith, E. L., Cohen, J. A., Pett, M. A., & Beck, S. L. (2010). The Reliability and Validity of a
Modified Total Neuropathy Score-Reduced (TNSr) and Neuropathic Pain Severity Items When Used
to Measure Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Patients Receiving Taxanes
and Platinums. Cancer Nursing, 33(3), 173-182. PMID: 20357656.
11. a,bBeck, S. L., Towsley, G. L., Berry, P. H., Brant, J. M., Smith, E. L. (2010) Measuring the quality
of care related to pain management: A multiple method approach to instrument development.
Nursing Research, 59(2), 85-92. PubMed PMID: 20216010.
12. a,bBeck, S. L., Towsley, GL, Pett, M, Berry, P. H., Smith, E. L., Brant, J. M., Guo, J. W. (2010).
Initial psychometric properties of the Pain Care Quality (PainCQ) Survey. Journal of Pain, 11(12),
1311-1319. PMID: 20537957.
13. *a,b,cSmith, E. L., Cohen, J. A., Pett, M. A., & Beck, S. L. (2011). The Validity of Chemotherapy-
Induced Peripheral Neuropathy (CIPN) Measurement Approaches When Used to Assess Taxane and
Platinum-Induced Peripheral Neuropathy in Oncology Outpatients. Oncology Nursing Forum,
38(2), 133-142. PMID: 21356652.
14. *a,bSmith, E. L., Bakitas, M. A., Homel, P., Piehl, M., Kingman, L., Fadul, C., & Bookbinder, M.
(2011). Preliminary Assessment of a Neuropathic Pain Treatment and Referral Algorithm for
Patients with Cancer. Journal of Pain and Symptom Management, 42(6), 822-838. PMID:
21820851.
15. a,b Smith, E. M. L., Skalla, K., Li, Z., Onega, T., Anton, K., Gallagher, S., Rhoda, J., Gates, C., &
Scott, M. R. (2012). Assessing cancer survivors’ needs using web-based technology: A pilot study.
Computer Informatics Nursing, 30(2). 71-81. PMID: 22258317.
16. a,bPett, M. A., Beck, S. L., Guo, J. W., Towsley, G. L., Brant, J. M., Lavoie Smith, E. M., Berry, P.
H., & Donaldson, G. (2013). Confirmatory factor analysis of the Pain Care Quality Survey
(PainCQ©). Health Services Research, 48(3), 1018-1038. EPub 3 Dec 2012, DOI: 10.1111/1475-
6773.12014. PMID: 23205503; PMCID: PMC3681241.
17. aSmith, E. L. (2013). Current Methods for Assessment and Management of Taxane-Associated
Chemotherapy-Induced Peripheral Neuropathy. Clinical Journal of Oncology Nursing, Suppl 17(1),
22-34. PMID: 23360700.
18. a,bSkalla, K; Smith, E. L., Li, Z., & Gates, C., & Litterini, A. (2013). Multidimensional Needs of
Caregivers for Patients With Cancer. Clinical Journal of Oncology Nursing. DOI
10.1188/13.CJON.17-05AP. PMID: 23956004.
19. a,bSmith, E. L., Barton, D. L., Qin, R., Aaronson, N. K., & Loprinzi, C. L. (2013). Assessing
patient-reported peripheral neuropathy: The reliability and validity of the European Organization for
Research and Treatment of Cancer QLQ-CIPN20 Questionnaire. Quality of Life Research. DOI
10.1007/s11136-013-0379-8. PMID 23543373, NIHMSID 568510.
20. a,bSmith, E. L., Pang, H., Cirrincione, C., Fleishman, S., Paskett, E. D., Ahles, T., Bressler, L. R.,
Fadul, C., Knox, C., Gilman, P. B., Shapiro, C. L. (2013). Effect of duloxetine on pain, function,
and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: A
randomized clinical trial. JAMA, 309(13), 1359 – 1367. PMID: 23549581; PMC3912515. NIHMSID
527232.
a. Featured in the JAMA Report (April 3, 2013) – A television clip highlighting this study
was aired on 183 television stations throughout the United States and was viewed by over
Ellen Lavoie Smith Last Revised 2/27/2020 27
17 million viewers and 82 million viewers viewed the video clip on-line.
http://jama.jamanetwork.com/journal.aspx; http://www.nursing.umich.edu/about-our-
school/news-portal/201304/2978#.UVwrTPUr27s.
b. http://www.everydayhealth.com/sanjay-gupta/the-legacy-of-chemo-that-can-last-for-
years-pain.aspx
21. a,bSmith, E. L., Li, L., Hutchinson, R., Ho, R., Burnette, W. B., Wells, E., Bridges, C., & Renbarger,
J. (2013). Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic
leukemia. Cancer Nursing. doi:10.1097/NCC.0b013e318299ad23. NIHMS487762, Publ.ID:
NCC200489 PMID: 2384252. PMCID: PMC3951303. NIHMSID 487762.
22. aSmith, E. M. L and Pang, H. (2013). Response to Letter to the Editor: Effect of duloxetine on pain
in chemotherapy-induced peripheral neuropathy. JAMA, 310 (5), 538-538. PMID: 23925632.
23. Cirrincione, C. T., Lavoie Smith, E. M., & Pang. H. (2014). Methodological considerations in the
design and implementation of clinical trials. Seminars in Oncology Nursing, 30(1):74-79. PMID:
24559783; PMCID: PMC3980716.
24. dKottschade, L. A., Bell, J., Klinger, K., & Smith, E. M. (2014). Nursing’s presence amidst the
changing cancer cooperative group landscape. Seminars in Oncology Nursing, 30(1), 32-37. PMID:
24559778.
25. a,bHershman, D., Lacchetti, C., Dworkin, R., Smith, E., Bleeker, J., Cavaletti, G., Chauhan, C.,
Gavin, P., Lavino, A., Lustberg, M., Paice, J., Schneider, B., Smith, T., Terstriep, S., Johnson, N.
W., Bak, K., & Loprinzi, C. L. (2014). Prevention and management of chemotherapy-induced
neuropathy in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice
Guideline. Journal of Clinical Oncology. doi:JCO.2013.54.0914. PMID: 24733808.
26. a,dBridges, C. M. & Smith, E. M. L. (2014). What about Alice? Peripheral neuropathy from taxane-
containing treatment for advanced non-small-cell lung cancer. Supportive Care in Cancer. DOI
10.1007/s00520-014-2317-x. PMID:24952242.
27. a,b,eSmith, E. M. L., Campbell, G., Tofthagen, C., Kottschade, L., Collins, M. L., Wharton, C.,
Ghosh, B., Ronis, R. L., Mallory, G. A., & Visovsky, C. (2014). Nursing knowledge, practice
patterns, and learning preferences regarding chemotherapy-induced peripheral neuropathy.
Oncology Nursing Forum, 41(6), 669–679. doi: 10.1188/14.ONF.669-679. PMID: 25355022.
28. Smith, E. M. L., Bridges, C. M., Kanzawa, G., Knoerl, R., Kelly, J. P., Berezovsky, A., & Woo, C.
(2014). Cancer treatment-related neuropathic pain – epidemiology and treatment: An update.
Current Pain and Headache Reports, 18 (459). doi 10.1007/s11916-014-0459-7. PMID: 25239766.
29. a,b,eVoepel-Lewis, T., Zikmund-Fisher, B., Smith, E. L., Zyzanski, S., & Tait, A. R. (2014 Epub
ahead of print). Parents’ Analgesic Trade-off Dilemmas: How Analgesic Knowledge Influences
their Decisions to give Opioids. International Clinical Journal of Pain. PMID: 25232863.
30. a,b,eVoepel-Lewis, T., Zikmund-Fisher, B., Smith, E. L., Redmund, R., Zyzanski, S., & Tait, A. R.
(2015). Opioid-related adverse events: Do parents recognize the signals? The Clinical Journal of
Pain. 31(3), 198-205. PMID: 24810650.
31. a,bPachman, D., Qin, R., Seisler, D., Smith, E. M. L., Beutler, A. S., Ta, L. E., Lafky, J., Johnston,
N. W., Ruddy, K., Bernath, A. M., Grothey, A., Loprinzi, C. (2015). Clinical Course of Oxaliplatin-
Induced Neuropathy – Results from the Randomized Phase III Trial N08CB (Alliance). Journal of
Clinical Oncology. 20; 33(30):3416-22. doi: 10.1200/JCO.2014.58.8533. PMID: 26282635.
32. a,b,eVoepel-Lewis, T., Zikmund-Fisher, B., Smith, E. L., Zyzanski, S., & Tait, A. R. (2015).
Parents’ Preferences Influence their Decisions to Withhold Opioids when Faced with Analgesic
Trade-off Dilemmas. Clinical Journal of Pain. 52(8):1343-53. doi: 10.1016/j.ijnurstu.2015.05.003.
PMID: 26001855.
Ellen Lavoie Smith Last Revised 2/27/2020 28
33. a,b,eSmith, E. M. L., Li, L., Chiang, C ., Thomas, K., Hutchinson, R., Wells, E. M., Ho, R. H.,
Skiles, J., Chakraborty, A., Bridges, C. M., & Renbarger, J. (2015). Patterns and severity of
vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia. Journal of
the Peripheral Nervous System, 20(1), 37-46. doi: 10.1111/jns.12114. PMID: 25977177. NIHMSID
725958.
34. a,b,eSchymik, F. A., Voepel-Lewis, T., & Smith, E.L. (2015). Parental Opioid Decision Making for
Children with and without Obstructive Sleep Apnea who underwent Tonsillectomy and
Adenoidectomy. Pain Management Nursing. 16(6):881-889. PMID: 26697816.
35. a,b,d,eKnoerl, R., Smith, E. L. (2015). Chronic Pain and Cognitive Behavioral Therapy: An
Integrative Review. Western Journal of Nursing Research. pii: 0193945915615869. [Epub ahead of
print]. PMID: 26604219.
36. a,bSmith, E. M. L., Pang, H., Ye, C., Cirrincione, C., Fleishman, S., Paskett, E. E., Ahles, T.,
Bressler, L. R., Le-Lindqwister, N., Fadul, C. E., Loprinzi C., & Shapiro, C. L. (2015). Predictors of
Duloxetine Response In Patients with Painful Oxaliplatin-Induced Peripheral Neuropathy (CIPN): A
Secondary Analysis of CALGB/Alliance 170601. European Journal of Cancer Care. PMID:
26603828 PMCID: PMC4879099. NIHMSID 775228.
37. a,bBeck, S. L., Brant, J. M., Donahue, R., Smith, E. M. L., Towsley, G. L., Berry, P. H., Guo, J-W.,
AI-Qaaydeh, S., Pett, M. A., & Donaldson, G. (2016). Oncology Nursing Certification: Relation to
Nurses' Knowledge and Attitudes about Pain, Patient-Reported Pain Care Quality, and Pain
Outcomes. Oncology Nursing Forum. 43(1), 67-76. doi:10.1188/16.ONF.67-76; PMID: 26679446.
38. a,b Pachman, D. R., Qin, R., Seisler, D., Smith, E. M. L., Puttabasavaiah, S., Novotny, P., Ruddy,
K., Beutler, A. S., Johnston, N. D. W., Staff, N., Grothey, A., Dougherty, P., Bennett, G., Cavaletti,
G., Loprinzi, C. L. (2016). Comparison of Oxaliplatin and Paclitaxel Induced Neuropathy.
Supportive Care in Cancer. 24(12), 5059-5068. PMID: 27534963.
39. a,b,d,eKnoerl, R., Dudley, W., Smith, G., Bridges, C., Kanzawa, G., & Smith, E. M. L. (2016). Pilot
Testing a Web-Based System for the Assessment and Management of Chemotherapy-Induced
Peripheral Neuropathy. Computers Informatics Nursing. PMID: 28002115 DOI:
10.1097/CIN.0000000000000320.
40. eMora, E., Smith, E. M. L., Mody, R., Donohue, C., & Hertz, D. (2016). Vincristine-Induced
Peripheral Neuropathy. 6(11):2416-2430. American Journal of Cancer Research. PMID: 27904761
PMCID: PMC5126263.
41. a,b,d,eKnoerl, R., Lee, D., Yang, J., Kanzawa-Lee, G., Bridges, C., Smith, G., & Lavoie Smith, E. M.
L. (2017). Examining the Impact of a Web-Based Intervention to Promote Patient Activation in
Chemotherapy-Induced Peripheral Neuropathy Assessment and Management. Journal of Cancer
Education. doi: 10.1007/s13187-017-1200-0. [Epub ahead of print] PMID: 28265863.
42. a,b,d,eKnoerl, R., Gray, E., Stricker, C., Mitchell, S. A., Kippe, K., Smith. G., Dudley, W. N., &
Smith, E. M. L. (2017). Electronic versus Paper-Pencil Methods for Assessing Chemotherapy-
Induced Peripheral Neuropathy. Supportive Care in Cancer. PMID: 28577231 DOI:
10.1007/s00520-017-3764-y.
43. a,b,eSmith, E. M. L., Haupt, R., Kelly, J. P., Lee-Ekblad, D., Kanzawa, G., Knoerl, R., Bridges, C.,
Alberti, P., Prasertsri, N., & Donohoe, C. (2017). The Content Validity of a Chemotherapy-Induced
Peripheral Neuropathy Patient-Reported Outcome Measure. Oncology Nursing Forum. 44(5):580-
588. doi: 10.1188/17.ONF.580-588. PMID: 28820525. PMCID: PMC5913659. NIHMSID 960212.
44. a,b,d,e Knoerl, R., Yang, J., Barton, D., Williams, D. A., Holden, J. E., Krauss, J. C., LaVasseur, B.,
& Smith, E. M. L. (2017). Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-
Ellen Lavoie Smith Last Revised 2/27/2020 29
Induced Peripheral Neuropathy: A Multicenter, Randomized, Wait-List Controlled Trial. Journal of
Pain. DOI: 10.1016/j.jpain.2017.11.009, PMID: 29229430.
45. a,b Le-Rademacher, J., Kanwar, R., Seisler, D., Pachman, D. R., Abyzov, A., Ruddy, K.J., Banck,
M. S., Smith, E. M. L., Dorsey, S. G., Aaronson, N. K., Sloan, J., Loprinzi, C. L., & Beutler, A. S.
(2017). Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification
of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical
trials. Supportive Care in Cancer. (11):3537-3544. doi: 10.1007/s00520-017-3780-y. Epub 2017 Jun
20. PMID: 28634656 PMCID: PMC5693734.
46. a,b,ePrasertsri, N., Kaewmanee, C., Khantittichit, P., Triyaphan, W., Smith, E. M. L, Lun, C. W., &
Diligently, B. (2017). Chemotherapy-Induced Peripheral Neuropathy (CIPN): A cross-sectional
study in Cancer Patients. Journal of Nursing, Public Health, and Education. 18 (3).ISSN: 2651-1908
Journal Online.
47. a,bSkiles, J.L., Li, C. H., Chien C. W., Smith, E. M. L., Olbara, G., Jones, D. R., Vik, T. A.,
Mostert, S., Abbink, F., Kaspers, G. J., Li, L. Njuguna, F., Sajdyk, T., & Renbarger, J. L. (2018).
CYP3A5 genotypeand its impact on vincristine pharmacokinetics and development of neuropathy in
Kenyan children with cancer. Pediatric Blood & Cancer. 65(3) doi: 10.1002/pbc.26854. PMID:
29115708, PMCID: PMC5766375.
48. a,bSmith, E. M. L., Banerjee, T., Yang, J., Bridges, C., Alberti, P., Sloan, J., & Loprinizi, C. (2018).
Psychometric Testing of the European Organisation for Research and Treatment of Cancer (EORTC)
QLQ-CIPN20 Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures
Standardization (CI-PeriNomS) and Alliance for Clinical Trials in Oncology (Alliance) A151408
Study Data. Cancer Nursing. PMID: 29649081 DOI: 10.1097/NCC.0000000000000596. NIHMSID
960208.
49. a,b,d,e Knoerl, R., Smith, E. M. L., & Chornoby, Z. (2018). Estimating the Frequency, Severity, and
Clustering of SPADE Symptoms in Chronic Painful Chemotherapy Induced Peripheral Neuropathy
(CIPN). Pain Management Nursing. doi:10.1016/j.pmn.2018.01.001. PMID: 29503217
50. a,b,e Smith, E. M. L., Knoerl, R., Yang, J., Kanzawa-Lee, G., & Bridges, C. (2018). In Search of a
Gold Standard Patient-Reported Outcome Measure for Use in Chemotherapy-Induced Peripheral
Neuropathy Clinical Trials. Cancer Control. PMID: 29480026 DOI: 10.1177/1073274818756608.
NIHMSID 960208.
51. a,b,d,e Kanzawa-Lee G, Harte S, Bridges C, Clauw DJ, Williams DA, Knoerl R, Lavoie Smith, EM.
Pressure Pain Phenotypes in Women Before Breast Cancer Treatment. (2018). Oncology Nursing
Forum. 45(4):483-495. doi:10.1188/18.ONF.483-495. PMID: 29947358
52. a,b,d,e Knoerl, R., Barton, D. L., Holden, J. E., Krauss, J., LaVasseur, E., & Smith, E.M.L. (2018).
Potential Mediators of Improvement in Painful Chemotherapy-Induced Peripheral Neuropathy via a
Web-based Cognitive Behavioral Intervention. Can Oncol Nurs J / Rev Can soins Infirm en Oncol.
28(3):178-183.
53. a,b,d,e Knoerl, R., Bridges, C., Lita Smith, G., Yang, J.J., & Kanzawa-Lee, G, & Smith, E.M.L.
(2018). Use of an Electronic Oncology Care Planning System to Improve Adherence to
Recommended Chemotherapy-Induced Peripheral Neuropathy Assessment and Management
Practices. Clinical Journal of Oncology Nursing. 22(5), E134 – E140.
54. a,b,eSmith, E. M. L., Zanville, N., Kanzawa-Lee, G., Donohoe, C., Bridges, C. M., Loprinzi, C., &
Yang, J. J. (2018). Rasch Analysis of the EORTC-QLQ CIPN20 Patient-Reported Outcome Measure
of Chemotherapy-Induced Peripheral Neuropathy. Supportive Care in Cancer. DOI:
10.1007/s00520-018-4553-y. PMID 30460399
Ellen Lavoie Smith Last Revised 2/27/2020 30
55. a,b Henry, N. L, Kidwell, K., Alsamarraie, C., Bridges, C. M., Kwiatkowski, C. K., Clauw, D. J.,
Smith, E. M. L., & Williams, D. A. (2018). Pilot Study of an Internet-based Self-Management
Program for Symptom Control in Patients with Early Stage Breast Cancer. JCO Clinical Cancer
Informatics. doi: 10.1200/CCI.17.00106. PMID: 30652562.
56. a,b,ePhligbuaa, W., Smith, E. M. L., & Barton, D. (2018). Psychometric properties of the Menopause
Specific Quality of Life Questionnaire among Thai women with a history of breast cancer. European
Journal of Oncology Nursing. 36:75-81. doi: 10.1016/j.ejon.2018.08.008. PMID: 30322513.
57. a,b Hertz, D. L., Kidwell, K. M., Vangipuram, K., Li, F., Pai, M. P., Burness, M., Griggs, J., Schoot,
A., Van Poznak, C., Hayes, D. F., Smith, E. M. L., & Henry, N. L. (2018). Paclitaxel plasma
concentration after the first infusion predicts treatment-limiting peripheral neuropathy. Clinical
Cancer Research. 24(15). doi: 10.1158/1078-0432.CCR-18-0656. PMID: 29703818.
58. aGewandter, J. S., Brell, J., Cavaletti, G., Dougherty. P., Evans, S., Howie, L., McDermotta, M. P.,
O’Mara, A., Smith, A. G., Dastros-Pitei, D., Gauthier, L., Haroutounian, S., Jarpe, M., Katz, N. P.,
Loprinzi, C., Richardson, R., Smith, E. M. L., Wen, P., Turk, D. C., Dworkin, R. H., Freeman, R.
(2018). Clinical Trial Design for Prevention of Chemotherapy-induced Peripheral Neuropathy:
ACTTION Recommendations. Neurology .91(9). doi: 10.1212/WNL.0000000000006083. PMID:
30054438 PMCID: PMC6133627.
59. a,b Sun, Y., Kim, J. A., Vangipuram, K., Hayes, D. F., Smith, E. M. L., Yeomans, L., Henry, N. L.,
Stringer, K. A., and Hertz, D. L. (2018). Pharmacometabolomics Reveals a Role for Histidine,
Phenylalanine and Threonine in the Development of Paclitaxel-induced Peripheral Neuropathy.
Breast Cancer Research and Treatment. 171(3): 657-666. doi: 10.1007/s10549-018-4862-3. PMID:
29946863 PMCID: PMC6119501.
60. a,b,d,e Kanzawa, G., Harte, S., Bridges, C. M., Brummett, C., Clauw, D., Williams, D., Knoerl, R., &
Smith, E. M. L. (2018). Trauma Exposure Predicts Cancer Treatment-Related Pain in Breast Cancer
Survivors. Cancer Nursing. doi: 10.1097/NCC.0000000000000687. [Epub ahead of print]. PMID:
30601264.
61. a,d,e Donohoe, C., & Smith, E., M. L. (2018). Psychological Predictors of Pain in Children and
Adolescents with Sickle Cell Disease: A Scoping Review. Journal of Pediatric Oncology Nursing.
doi: 10.1177/1043454218819457. [Epub ahead of print]. PMID: 30565483.
62. a,bLi, L., Sajdyk, T., Smith, E. M. L., Chang, C. W., Li, C., Ho, R. H., Hutchinson, R., Wells, E., &
Renbarger, J. L. (2018). Genetic Variants Associated with Vincristine-Induced Peripheral
Neuropathy in Two Independent Populations of Children with Acute Lymphoblastic Leukemia.
Clinical Pharmacology and Therapeutics. 105(6); 1421-1428. doi: 10.1002/cpt.1324. PMID:
30506673.
63. a,d,eNgamkham, S., Holden, J. E., & Smith, E. L. (2019). Mindfulness intervention for cancer-
related pain. Asia Pacific Journal of Oncology Nursing. 6; 161-169.
64. a,d,e Lee, D., Kanzawa-Lee, G., Knoerl, R., Wyatt, G., and Smith, E. M. L. (2019). Internal and
External Threats to Validity in Phase III Prevention and Treatment Trials of Chemotherapy-Induced
Peripheral Neuropathy: A Systematic Review. Asia-Pacific Journal of Oncology Nursing. Accepted
for publication 4 – 23 – 2019.
65. Smith, E. M. L. (2019). Pharmacologic treatments for chronic cancer-related pain: Does anything
work? Editorial. Journal of Clinical Oncology. [Epub ahead of print]. doi.
http://ascopubs.org/doi/full/10.1200/JCO.18.01567
66. aDorsey, S. G., Kleckner, I. R., Barton, D., Mustian, K., O-Mara, A., St. Germain, D., Cavaletti, G.,
Danhauer, S., Hershman, D., Hohmann, A., Hoke, A., Hopkins, J., Kelly, K., Loprinzi, C., McLeod,
H., Mohile, S., Paice, J., Rowland, J., Salvemini, D., Segal, R., Smith, E. L., Stevens, W. M., &
Ellen Lavoie Smith Last Revised 2/27/2020 31
Janelsins, M. C. (2019). Commentary: Recommendations for planning clinical trials to prevent or
treat chemotherapy-induced peripheral neuropathy (CIPN). Journal of National Cancer Institute.
Accepted 1/23/19.
67. a,d,e Kanzawa-Lee, G., Donohoe C., Knoerl, R., Bridges, C. M., & Smith, E. M. L. (2019).
Mechanisms, predictors, and challenges in assessing and managing painful chemotherapy-induced
peripheral neuropathy. Seminars in Oncology Nursing. 35, 253-260.
68. a,b Knoerl, R., Smith, E.M.L., Han, A., Doe, A., Scott, K., Berry, D. (2019). Characterizing Patient-
Clinician Chemotherapy-Induced Peripheral Neuropathy Assessment and Management
Communication Approaches. Patient, Education, Counseling. Accepted for publication 4 – 5 – 2019.
69. aPotempa, K., Furspan, P., Rajataramya, B., Barton, D., Singha-Dong, N., & Stephenson, R.,
Smith, E. M. L., Davis, M., Dinov, I., Hampstead, B., Saslow, L., Aikens, J. (2019). Impact of using
a broad-based multi-institutional approach to build capacity for non-communicable disease research
in Thailand. Health Research Policy and Systems. Accepted for publication 5 – 19 – 2019.
70. a,bSajdyk, T. J., Boyle, F. A., Foran, K. S., Yan Tong, Y., Pandya, P., Smith, E. M. L., Ho, R.,
Wells, E., & Renbarger, J. L. (In Press). Obesity as a Potential Attribute for Vincristine Induced
peripheral Neuropathy. Pediatric Blood & Cancer. Accepted for publication 7 – 10 – 2019.
71. a,b,d,e Soulia, S., Duffy, E., Morley, K., & Smith, E. M. L. (In Press). Implementation of a
Survivorship Care Plan Program in a Community-Based Oncology Clinic. Journal of the Advanced
Practitioner in Oncology. Accepted for publication 7 – 11 – 2019.
72. a,b,d Kanzawa, G. & Smith, E. M. L. (In Press). Exercise interventions for chemotherapy-induced
peripheral neuropathy: A literature review. Cancer Nursing. Accepted for publication 12 – 06 –
2019.
73. a,bMarcath, L. A., Kdwell, K. M., Smith, E. M. L., Vangipuram, K., Gersch, C., Burness, M. L.,
Griggs, J. J., Schott, A. F., Van Poznak, C., Hayes, D. F., Henry, N. L., Beutler, A. S., & Hertz, D.
(In Press). L. EPHA genetics for prediction of paclitaxel-induced peripheral neuropathy sensitivity..
British Journal of Clinical Pharmacology. Accepted for publication 12 – 2019.
74. Wang, H-L., Cousin, L., Fradley, M. G, Donovan, K. A., Smith, B., Smith, E. M. L., & Buck, H. G.
(In Press). Exercise interventions in cardio-oncology populations: A scoping review of the literature.
Journal of Cardiovascular Nursing. 12 – 09 – 2019.
75. a,d,eKnoerl, R., Gilchrist, L., Kanzawa-Lee, G., Donohoe, C., Bridges, C., & Lavoie Smith, E. M.
(2020). Practice rehabilitation for chemotherapy-induced peripheral neuropathy. Seminars in
Oncology Nursing. Jan 18:150983. doi: 10.1016/j.soncn.2019.150983. [Epub ahead of print]
76. a,b,d,eSmith, E. M. L, Donohoe, C., Kanzawa-Lee, G., Alberti, P., Cavaletti, G., Saad, R., Bridges,
C., & Park, S. (In Press). Pediatric chemotherapy-induced peripheral neurotoxicity measurement
approaches: A systematic review. Lancet Heamatology.
Book Chapters
1. Smith, E. L. Cancer Pain (2004). In C. Varricchio (Ed), A Cancer Source Book for Nurses, Eighth
Edition. American Cancer Society, Atlanta GA.
2. Smith, E. L., & Ferrans, C. E. (2009). The Role of Cooperatives in Advancing Oncology Nursing
Science. In Advancing Oncology Nursing Science. Pittsburgh: Oncology Nursing Society
Publishing Company.
3. Smith, E.M. L. (2010). Peripheral Neuropathy. In L. K. Sheldon (Ed), The Cancer Survivorship
Series. Boston MA: Jones & Bartlett Publishers.
Ellen Lavoie Smith Last Revised 2/27/2020 32
4. Smith, E.L., & Cohen, J. (2011). Neuropathies in cancer survivors. In J. Lester & P. Schmitt (Eds.),
Cancer rehabilitation and survivorship: Transdisciplinary approaches to personalized care.
Pittsburgh, PA: Oncology Nursing Society.
5. Smith, E.L, & Zanville, N. (2015). Peripheral Neuropathy. In C. Brown (Ed.), A Guide to
Oncology Symptom Management. Pittsburgh, PA: Oncology Nursing Society.
Other Media
Lay Media Article Highlight
1. a,bSmith, E. L., Pang, H., Cirrincione, C., Fleishman, S., Paskett, E. D., Ahles, T., Fadul, C., Knox,
C., & Shapiro, C. L for the Cancer and Leukemia Group B. (2012). Abstract 91721: CALGB
170601: A phase III double blind trial of oral duloxetine for treatment of painful chemotherapy-
induced peripheral neuropathy (CIPN). (Abstract 91721). Proceedings of the American Society of
Clinical Oncology (ASCO). Accepted for Scientific Symposium Presentation and ASCO Press
Program Presentation.
Highlighted in the lay media June 2012:
1. New York Times - http://www.nytimes.com/2012/06/04/health/glaxosmithkline-
melanoma-drug-prolongs-patients-lives.html?_r=1
2. US News and World Report - http://health.usnews.com/health-
news/news/articles/2012/06/04/antidepressant-cymbalta-might-ease-chemo-linked-pain
3. WebMD - http://www.webmd.com/cancer/news/20120604/cymbalta-may-relieve-chemo-
induced-pain-tingling
4. Medical News Today - http://www.medicalnewstoday.com/articles/246218.php
5. Bioscience Today - http://biosciencetechnology.com/News/2012/06/Antidepressant-
Drug-Duloxetine-Helps-Relieve-Pain-from-Chemotherapy,-Study-Finds/
6. HealthFinder.gov - http://www.healthfinder.gov/news/newsstory.aspx?Docid=665382
7. Cancer Survivors Network - http://csn.cancer.org/node/241316
8. Doctor’s Lounge - http://www.doctorslounge.com/index.php/news/hd/29542
9. Rx List - http://www.rxlist.com/script/main/art.asp?articlekey=158965
10. medpage Today -
http://www.medpagetoday.com/HematologyOncology/Chemotherapy/33078
11. KLAS CBS New- Nevada - http://www.8newsnow.com/story/18691536/antidepressant-
cymbalta-might-ease-chemo-linked-pain
12. MedicineNet.com - http://www.medicinenet.com/script/main/art.asp?articlekey=158901
13. ThirdAge.come - http://www.thirdage.com/breast-cancer/cymbalta-for-post-chemo-pain
14. CFVS CBS News - http://www.kfvs12.com/story/18691536/antidepressant-cymbalta-
might-ease-chemo-linked-pain
15. eCancerNews - http://ecancer.org/news/2892
16. WAFB CBS News - http://www.wafb.com/story/18691536/antidepressant-cymbalta-
might-ease-chemo-linked-pain
17. Myfox Austin - http://www.myfoxaustin.com/story/18691536/antidepressant-cymbalta-
might-ease-chemo-linked-pain
18. Fox 12 Oregon - http://www.kptv.com/story/18691536/antidepressant-cymbalta-might-
ease-chemo-linked-pain
19. Medical Daily - http://medicaldaily.com/news/20120604/10143/antidepressant-
duloxetine-chemotherapy.htm
Ellen Lavoie Smith Last Revised 2/27/2020 33
20. WECT - http://www.wect.com/story/18691536/antidepressant-cymbalta-might-ease-
chemo-linked-pain
21. Drug Policy Central - http://drugpolicycentral.com/bot/article/webmd8277.htm
22. WATE – Knoxville - http://www.wate.com/story/18691536/antidepressant-cymbalta-
might-ease-chemo-linked-pain
23. WGEM - http://www.wgem.com/story/18691536/antidepressant-cymbalta-might-ease-
chemo-linked-pain
24. CBS Atlanta - http://www.cbsatlanta.com/story/18691536/antidepressant-cymbalta-
might-ease-chemo-linked-pain
25. Yahoo Daily News -
http://article.wn.com/view/2012/06/04/Antidepressant_Cymbalta_Might_Ease_ChemoLi
nked_Pain/
26. Fox 8 New Orleans - http://www.fox8live.com/story/18691536/antidepressant-cymbalta-
might-ease-chemo-linked-pain
27. Michigan Record - http://www.ur.umich.edu/update/archives/120606
28. NCI Bulletin - http://www.cancer.gov/ncicancerbulletin/061212
29. Cure Magazine 2014
2. 2016-2107 - ASCO University Grant Writing On-line Training Course Faculty
http://university.asco.org/grant-writing
Monographs
1. Sarna, L., Smith, E. L., Frankel, C. Rittenberg, C. N., Varricchio, C., & Wilkie, D. (1996).
Overview of Non-small Cell Lung Cancer (Module One). Vancouver: GlaxoWellcome.
2. Varricchio, C., Frankel, C., Rittenberg, C. N., Sarna, L., Smith, E. L., & Wilkie, D. (1997).
Assessing Quality of Life in Non-small Cell Lung Cancer Patients (Module Two). Vancouver:
GlaxoWellcome.
3. Lung Cancer Primer and CD-ROM, Evolution Health Care , 2002
4. Meniscus On-Line Lung Cancer Module for MDs and Nurses, 2002
5. Finding the Balance: Providing Patient-Driven Evidence-Based Treatment and Care, Oncology
Nursing Society, 2007
Letters/Other
1. Smith, E. L. (1990). Patient education of cancer patients. Research Review: Studies for Nursing
Practice, 7(3):2.
2. Smith, EL. (1992). Acute Respiratory Distress Syndrome. CALGB Newsletter, Fall, 1:5.
3. Smith, E. L., & Hammond, S. (1994). Chemoprevention of Second Primary Lung Cancers: A
Recruitment Strategy for CALGB 9293. CALGB Newsletter, Summer, 3(2):10.
4. Smith, E. L. (1996). Informed Consent: What does it mean? CALGB Newsletter, Fall, 5(3):6.
5. Smith EL. Commentary on Treatment of elderly patients with small cell lung cancer [original
article by Keane R appears in LUNG CANCER 1993;9(Suppl 1):S91-8]. ONS Nursing Scan in
Oncology, 3(1):19, 1994 Jan-Feb.
6. Smith EL. Commentary on Future directions in the management of non-small cell lung cancer
[original article by Bunn P appears in LUNG CANCER 1993;9(Suppl 2):S91-107]. ONS Nursing
Scan in Oncology, 3(1):19,1994 Jan-Feb.
7. Smith EL. Commentary on Extensive small cell lung cancer [original article by Comis R appears in
LUNG CANCER 1993;9(Suppl 1):S27-39]. ONS Nursing Scan in Oncology, 3(2):18, 1994 Mar-
Apr.
Ellen Lavoie Smith Last Revised 2/27/2020 34
8. Smith EL. Commentary on The role of respiratory function testing [original article by Pierce R
appears in LUNG CANCER 1993;9:179-84]. ONS Nursing Scan in Oncology, 2(6):16-7, 1993 Nov-
Dec.
9. Smith EL. Commentary on Surgery for small cell lung cancer [original article by Ginsberg R
appears in LUNG CANCER 1993;9:275-80]. ONS Nursing Scan in Oncology, 2(5):17, 1993 Sep-
Oct.
10. Smith EL. Commentary on Is there a role for prophylactic cranial irradiation (PCI) in the
management of small cell lung cancer? [original article by Kristjansen P appears in LUNG
CANCER 1993;9:265-74]. ONS Nursing Scan in Oncology, 2(5):18, 1993 Sep-Oct.
11. Smith EL. Commentary on The role of retinoids in preventing second lung cancers [original article
by Benner S et al appears in LUNG CANCER 1993;9:343-50]. ONS Nursing Scan in Oncology,
2(4):16, 1993 Jul-Aug.
12. Smith EL. Commentary on Chemotherapy versus best supportive care for unresectable non small
cell lungcancer: is it really worthwhile? [original article by Feld R appears in LUNG CANCER
1993;9:391-6]. ONS Nursing Scan in Oncology, 2(4):17, 1993 Jul-Aug.
13. Smith EL. Commentary on How to optimize the use of chest irradiation in small cell lung cancer?
[original article by Benk V et al appears in LUNG CANCER 1992;8:169-173]. ONS Nursing Scan
in Oncology, 2(3):13, 1993 May-Jun.
14. Smith EL. Commentary on The role of colony stimulating factors as an adjunct to lung cancer
chemotherapy: a commentary [original article by Crawford J et al appears in LUNG CANCER
1992;8(3,4):153-8]. ONS Nursing Scan in Oncology, 2(2):13, 1993 Mar-Apr.
15. Smith EL. Commentary on Malignant mesothelioma: prognostic factors in a prospective study of
98 patients [original article by Tammilehto L appears in LUNG CANCER 1992;8(3/4):175-84].
ONS Nursing Scan in Oncology, 2(2):17, 1993 Mar-Apr.
16. Smith EL. Commentary on The newly registered nurse and the cancer patient: an educational
evaluation [original article by Corner J et al appears in INTL J NURS STUD 1992;29(2):177-90].
ONS Nursing Scan in Oncology,1(3):21, 1992 Sep-Oct.
17. Smith EL. Commentary on Long-term survival of "extensive" small cell lung cancer by combined
treatment modalities [original article by Cha R et al appears in LUNG CANCER 1992;8:101-6].
ONS Nursing Scan in Oncology, 2(1):14, 1993 Jan-Feb.
18. Smith EL. Commentary on Treatment of non-small cell lung cancer: new cytostatic agents [original
article by Sorensen J appears in LUNG CANCER 1994;10(3,4):173-87]. ONS Nursing Scan in
Oncology, 3(4):15, 1994 Jul-Aug.
19. Smith EL. Commentary on Biology of lung cancer [original article by Stahel R appears in LUNG
CANCER1994;10(Suppl1):S59-65]. ONS Nursing Scan in Oncology, 3(5):15, 1994 Sep-Oct.
20. Smith EL. Commentary on Does adjuvant chemotherapy decrease distant metastasis formation in
patients with on-small cell lung cancer? [original article by Green M appears in LUNG CANCER
1994;10(Suppl1):S187-94]. ONS Nursing Scan in Oncology, 3(6):18, 1994 Nov-Dec.
21. Smith EL. A Step Forward for Cooperative Group Cancer Nursing Research. The CAL-GAB,
11(3):1,4, 7, 2002 Summer.
22. Smith, E. M. L. (2010). Commentary on Chemotherapy-induced peripheral neuropathy in cancer
survivors [original article by Boland, B. A., Sherry, V., & Polomano, R. C. appears in ONCOLOGY
Nurse Edition 2010 23(2), 1-8]. Helping patients to cope with CIPN. ONCOLOGY Nurse Edition.
23(2), 8-9.
Ellen Lavoie Smith Last Revised 2/27/2020 35
23. dKnoerl, R., Kanzawa, G., & Smith, E. M. L. (2015). Chemotherapy-induced peripheral
neuropathy: Answering your questions about this common nerve condition caused by chemotherapy
treatment. Coping with Cancer. September/October, 10.
a) Featured on Coping with Cancer Website Homepage January 2016;
http://copingmag.com/cwc/index.php/feature_article/chemotherapy_induced_peripher
al_neuropathy
b) Featured on https://www.facebook.com/CopingWithCancer and
https://www.twitter.com/Coping_Cancer
Abstracts
1. a,bMeehan, K., Zacharski, L., Eaton, W., Smith, E., Hammond, S., & Maurer, L. H. (1993). A
phase I-II pilot study evaluating urokinase and warfarin with cisplatin and etoposide in small cell
lung carcinoma. (Abstract 1199). Program/Proceedings of the American Society of Clinical
Oncology, 12.
2. a,bDavis, T. H., Maurer, L. H., Titus-Ernstoff, L., Smith, E., Hammond, S., Doolittle, M., West, P.,
Nelson, E., and The Northern New England Cancer Consortium: DHMC, Lebanon, NH. (1995).
Use of clinical trials for education of community physicians. (Abstract 17) Journal of Cancer
Education, 10(Suppl. 3), 13.
3. aSmith, E. L., O’Donnell, J., Coburn, K. M., Hunt, J. M., Meyer, L. P., Simon, R. M., Sleeth, M.
K., Shamos, E. F., & Youells, F. E. (1996). Patient education improvement efforts at a
comprehensive cancer center. (Abstract 90). Journal of Cancer Education, 11(Suppl. 3), 33.
4. a,bSmith, E., Whedon, M., Bookbinder, M., Fadul, C., Meyer, L., Fanciullo, G., Rose, R., Deleo, J.,
Maurer, L.H., Mills, L., Ahles, T., Plunket, M., Drake, C. (1999). A Multidisciplinary Quality
Improvement Approach to Improve Neuropathic Pain Management in Cancer Patients. (Abstract 4).
Program Proceedings of 2nd International Conference on Mechanisms and Treatment of
Neuropathic Pain, Washington, D.C.
5. a,bSmith, E., Meyer, L., Whedon, M., Bookbinder, M., Fadul, C., Fanciullo, G., Rose, R., Deleo, J.,
Maurer, L.H., Mills, L., Ahles, T., Plunket, M., Drake, C. (2000). A Multidisciplinary Quality
Improvement Approach to Improve Neuropathic Pain Management in Cancer Patients. Poster
presentation at the Oncology Nursing Society Annual Conference.
6. a,bSmith, E. L., Meyer, L., Bakitas, M., Bookbinder, M., Homel, P., Fadul, C., Kingman, L. (2005).
Effects of a Neuropathic Pain Algorithm on Patient and Nursing Outcomes. Poster presentation at
8th International Conference on the Mechanisms and Treatment of Neuropathic Pain, San Francisco,
CA.
7. a,bBeck, S. L., Berry, P., Brant, J., Smith, E., & Towsley, G. (2007). Content validity of the Pain
and Nursing Care Quality (PANCQ) Survey. Oncology Nursing Forum, 34(2), 516.
8. a,bSmith, E. L., Meyer, L. P., Bakitas, M., Homel, P., Kingman, L., Fadul, C. E., & Bookbinder, M.
(May 2008). The Influence of Improved Neuropathic Pain Screening, Assessment, and Treatment
on Patient and System Outcomes. Oncology Nursing Forum, 35, (3), 510. Poster presentation at
Oncology Nursing Society Congress, Atlanta, GA.
9. a,bSmith, E. L., Cohen, J., Pett, M., & Beck, S. L. (2008). Clinimetric Properties of Chemotherapy-
Induced Peripheral Neuropathy (CIPN) Measurement Approaches. Poster presentation at 22nd
Annual Neuroscience Day, Dartmouth College.
10. a,bBeck, S. L., Berry, P., Towsley, G., Brant, J., & Smith, E. L. (2008). Development of the Pain
and Nursing Care Quality (PaNCQ) Survey: Phase 3. Poster presentation at the Western Institute of
Nursing Research Conference.
Ellen Lavoie Smith Last Revised 2/27/2020 36
11. aSchaal, A., DiSalvo, W., Scott, M., Gates, C., Urquhart, L., Skalla, K., & Smith, E. (2008).
Creating and Implementing Transitional Care Summaries. (Abstract 3503). Oncology Nursing
Forum, 35, (6), 978. Poster presentation at the Oncology Nursing Society Advanced Practice
Nursing Conference, Seattle, WA.
12. a,bSmith, E. L., Cohen, J. A., Pett, M. A., & Beck, S. (Accepted 2008 – Declined presentation).
Clinimetric Properties of Chemotherapy-Induced Peripheral Neuropathy (CIPN) Measurement
Approaches. Oncology Nursing Society Advanced Practice Nursing Conference, Seattle, WA.
13. a,bGuo, JW, Pett, M, Beck, SL, Towsley, GL, Brant, J, Smith, EL, Berry, P. (2009) Confirmatory
Factor Analysis of the Pain Care Quality Survey. Poster presentation at the Society for Behavioral
Medicine Conference, Montreal, Canada.
14. a,bDonovan, H.S., Nolte, S., Pipe, T., Ulrich, C., Hooke, C., Lillington, L., Hinds, P., Barton, D.,
Homan, S., Smith, E.M.L., Bruner, D., & Mallory, G. (2009). ONS Foundation Multisite Research
Training Program: Lessons Learned Two Years Out. (Abstract 3900). Poster presentation at the
Oncology Nursing Society Congress.
15. a,bSkalla, K., Smith, E. L., Anton, K., Gallagher, S., Onega, T., & Dietrich, A. (2010). Statewide
Cancer Survivor Web Survey: A Translational Research Method (Abstract 4293). Poster
presentation at the Oncology Nursing Society Congress, San Diego, CA.
16. a,bSmith, E.L., Skalla, K., Onega, T., Anton, K., Gallagher, S., Rhoda, J., DiSalvo, W., & Dietrich,
A. (2010). The cancer survivor survey: Using web-based technology to assess cancer survivor
challenges (Abstract 9054). Proceedings of the American Society of Clinical Oncology, 28(Suppl.
15).
17. a,bBrant, J. M., Towsley, G. L., Berry, P., Beck, S. L., Smith, E., Pett, M. A., Guo, J. W., &
Donohue, R. B. (2010). Nurses’ Knowledge and Attitudes about Pain Management: Certification
Makes a Difference 2010 Poster presentation at the Council for the Advancement of Nursing Science
Meeting, Washington, D.C.
18. a,bThornton, D., Smith, E. L., Skalla, K., Li, Z., Onega, T., Anton, K., Gallagher, S., Rhoda, J.,
DisSalvo, W., & Dietrich, A. (2011). Using web-based technology to assess psychological distress
experienced by breast cancer survivors across the survivorship continuum. Poster presentation at the
University Of Michigan School Of Nursing Dean’s Research Day. Ann Arbor, MI. Received 3rd
place award for best poster presentation. (Faculty mentor for Thornton).
19. a,bCook, T, Katapodi, M. C., Smith, E. L., Pierce, P. F., Northouse, L. L., Liu, G., Milliron, K., &
Merajver, S. D. (2011). Decisional Conflict and Family Communication in Genetic Testing for
Hereditary Breast and Ovarian Cancer. Poster presentation at the Midwest Nursing Research
Society Annual Conference, Columbus, OH.
20. a,bTowsley, G., Guo, J., Brant, J., Smith, E., Perry, P., Pett, M., & Beck, S. (2012). Predictors of
Pain in Older Hospitalized Cancer Patients. Gerontological Society of America 65th Annual
Scientific Meeting, San Diego, CA.
21. Smith, E. L. (2012). Plagiarism. MICHR Annual Research Education Symposium: Ann Arbor, MI
22. a,bSmith, E. L., Pang, H., Cirrincione, C., Fleishman, S., Paskett, E. D., Ahles, T., Fadul, C., Knox,
C., & Shapiro, C. L for the Cancer and Leukemia Group B. (2012). Abstract 91721: CALGB
170601: A phase III double blind trial of oral duloxetine for treatment of painful chemotherapy-
induced peripheral neuropathy (CIPN). (Abstract 91721). Proceedings of the American Society of
Clinical Oncology (ASCO). Accepted for Scientific Symposium Presentation and ASCO Press
Program Presentation.
Selected to be included in the Best of ASCO® program. The Best of ASCO® is an educational
initiative that condenses highlights from ASCO’s Annual Meeting into a two-day program. The
Ellen Lavoie Smith Last Revised 2/27/2020 37
purpose of this initiative is to increase global access to cutting-edge science. Abstracts were
selected according to specific criteria and reflect research that is relevant and significant in
oncology today. In addition to three domestic Best of ASCO® meetings, there will also be
approximately fifteen International Best of ASCO® Meetings.
23. a,bSmith, E. L., Renbarger, J., Hutchinson, R., Wells, E., Ho, R., & Burnette, W. B. (2012).
Measuring Vincristine-Induced Peripheral Neuropathy in Children. Accepted for podium
presentation at the Connections: Advancing Care through Science Conference in Phoenix, Arizona
on November 16-18, 2012.
24. a,b Smith, E. L., Pang, H., Cirrincione, C., Fleishman, S., Paskett, E. D., Ahles, T., Fadul, C., Knox,
C., & Shapiro, C. L for the Cancer and Leukemia Group B. (2012). Abstract 91721: CALGB
170601: A phase III double blind trial of oral duloxetine for treatment of painful chemotherapy-
induced peripheral neuropathy (CIPN). Invited podium and abstract; American Society of
Hematology (ASH).
25. a,b Towsley, G. L., Guo, J., Brant, J., Smith, E., Berry, P. H., Pett, M., Beck, S. (2012). Predictors of
pain intensity in older hospitalized cancer patients. Gerontologist, 52, 568-569.
26. a,bSmith, E. L., Li, L., Hutchinson, R., Ho, R., Burnette, W. B., Wells, E., Bridges, C., Kelly, J. P,
Thomas, K. & Renbarger, J. (2013). Measuring Vincristine-Induced Peripheral Neuropathy in
Children. Abstract and poster presented at University of Michigan MICHR Research Symposium
and the School of Nursing’s Dean’s Research Day - Received 1st prize award on Dean’s Research
Day.
27. a,b Berezovsky, A., Sengupta, M., Brummett, C., Henry, L., Harte, S., Williams, D., Tsodikov, A.,
Bridges, C., Kolarik, E., & Smith, E. L. (2013). Does a pain prone phenotype predict post breast
cancer pain? Abstract & poster presented at University of Michigan MICHR Research Symposium.
28. a,b Thomas, K., Smith, E. L., Li, L., Hutchinson, R. J., Wells, E., Ho, R., Burnette, W. B.,
Robertson, P. L., Bridges, C., Kelly, J. P., Knoerl, R., Chiang. C. W., & Renbarger. (2014).
Describing the incidence, patterns, and severity of vincristine-induced peripheral neuropathy in
children with acute lymphoblastic leukemia. Abstract & poster presented at University of Michigan
School of Nursing’s Dean Research Day - Received 1st Place Award.
29. abPachman, D., Qin, R., Seisler, D., Smith, E. M. L., Beutler, A. S., Ta, L. E., Lafky, J., Johnston,
N. W., Ruddy, K., Bernath, A. M., Dakhil, S. R., Grothey, A., Loprinzi, C. (In Press). A comparison
of the natural history of oxaliplatin- and paclitaxel-induced neuropathy (NCCTG N08C1,
N08CB/Alliance). American Society of Clinical Oncology.
30. b,dKanzawa, G., Smith, E. L., Brummett, C., Clauw, D., Henry, L.N., Harte, S., Williams, D.
Tsodikov, A., Bridges, C., Kolarik, E., Kelly, J. P., Prasertsri, N., Phligbua, W., Berezovsky, A., &
Sengupta. M. (2015). The Painful Truth: Chronic Neuropathic Pain Patterns in Breast Cancer
Surgery Patients. University of Michigan Dean’s Research Day Poster Presentation. Ann Arbor, MI.
31. b,dKnoerl, R., Smith, E. L. (2015). Chronic Pain and Cognitive Behavioral Therapy: A Literature
Review & Directions for Future Research. University of Michigan Dean’s Research Day Poster
Presentation. Ann Arbor, MI.
32. a,b,dKnoerl, R., Smith, E. L. (2015). Chronic Pain and Cognitive Behavioral Therapy: A Literature
Review & Directions for Future Research. MNRS Doctoral Student Poster Presentation,
Indianapolis, IN.
33. bSchymik, F. A., Voepel-Lewis, T., & Smith, E.L. (2015). Parental Opioid Decision Making for
Children with and without Obstructive Sleep Apnea who underwent Tonsillectomy and
Adenoidectomy. University of Michigan Dean’s Research Day Poster Presentation. Ann Arbor, MI.
Ellen Lavoie Smith Last Revised 2/27/2020 38
34. a,bRuddy, K., Pachman, D. R., Qin, R., Seisler, D., Smith, E. M. L., Puttabasavaiah, S., Novotny,
P., Ta, L. E., Beutler, A. S., Johnston, N. D. W., Staff, N., Grothey, A., Dakhil, S., Loprinzi, C. L.
(2015). A comparison of the natural history of Oxaliplatin- and Paclitaxel-induced neuropathy –
N08C1, N08CB (Alliance). American Society of Clinical Oncology.
35. a,bErickson, J. M., Brant, J. M., Smith, E. L., & Beck, S. L. (2015) The Pain Experience of
Hospitalized Young Adults with Cancer. Poster Presentation. Critical Mass Young Adult
Conference, Chicago, IL. Received third place poster award.
36. a,bSmith, E. M. L., Yang, J., Banerjee, T., Loprinizi, C., Cavaletti, G., Bridges, C., Haupt, R.,
Kanzawa, G., Knoerl, R., Lee-Ekblad, D., Prasertsri, N. (2016). The reliability, validity, and
sensitivity of the European Organization for Research and Treatment of Cancer (EORTC) Quality of
Life Questionnaire-chemotherapy-induced Peripheral Neuropathy (QLQ-CIPN-20). Podium
Symposium Presentation – Midwestern Nursing Research Conference, Milwaukee, WI. March 2016.
37. a,b,d Knoerl, R., Bridges, C., Smith, G., Scheu, K., Prasertsri, N., Phligbua, W., Kanzawa, G., Haupt,
R., Lee-Ekblad, D., Still, N., & Smith, E. M. L. (2016). Pilot testing a web-based system for
assessment and management of chemotherapy-induced peripheral neuropathy. Symposium
Presentation – Midwestern Nursing Research Conference, Milwaukee, WI. March 2016.
38. a,b,d Kanzawa, G., Bridges, C., Prasertsri, N., Kelly, J., Phligbua, W., Berezovsky, A. & Smith, E.
M. L. (2016). The Painful Truth: Chronic neuropathic pain and chemotherapy-induced peripheral
neuropathy in breast cancer surgery patients – Midwestern Nursing Research Conference,
Milwaukee, WI. March 2016.
39. a,b,d Lee, D., Bridges, C., Knoerl, R., Kanzawa, G., Smith, G., Scheu, K., Still, N., & Smith, E. M.
L. (2016). Symptom reporting, monitoring, and management for breast cancer patients using the
web-based OnQ care planning system – Midwestern Nursing Research Conference, Milwaukee, WI.
March 2016.
40. a,b,d Kanzawa, G., & Smith, E. M. L. (2016). The effects of exercise and physiotherapy on
peripheral neuropathy: A literature review. Poster Presentation - Midwestern Nursing Research
Conference, Milwaukee, WI. March 2016.
41. a,b,d Lee, D., Haupt, R., Kelly, J. P., Donohue, C., & Smith, E. M. L. (2016). Cognitive Interviewing
Approaches for Assessing Content Validity – Poster Presentation – Dean’s Research Day, Ann
Arbor, MI. April 2016.
42. a,b,d Kippe, K., Knoerl, R., & Smith, E. M. L. (2016). Electronic versus Paper-Pencil Methods for
Assessing Chemotherapy-Induced Peripheral Neuropathy and Associated Neuropathic Pain – Poster
Presentation – Dean’s Research Day, Ann Arbor, MI. April 2016.
43. Kanzawa, G., Harte, S.E., Brummett, C., Clauw, D.J., Williams, D.A., Tzodikov, A., Halvorson,
M.E., Kolarik, E., Kelly, J.P. IV, Bridges, C. M., Smith, E. L. (2016). Comparing Pain Sensitivity
Subgroups in Women before Breast Cancer Surgery – Poster Presentation – Dean’s Research Day,
Ann Arbor, MI. April 2016.
44. Ross, W., Smith, E., Ho, R., Wells,E., Sadjdk,T., Tehn, J., Li, L., Renbarger, J. (2016). Potential
Biomarkers for Early Detection of Neuropathy in Pediatric ALL Patients. (Abstract). Society of
Neuroscience, November, 2016.
45. a,b.dKnoerl, R., Yang,. J., Barton, D. L., Williams, D. A., Holden, J. E., Krauss, J. C., Bridges, C.,
Smith, E. M. L. (2017). Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-
Induced Peripheral Neuropathy: A Multicenter, Single Blind, Randomized, Wait-List Controlled
Trial. (Abstract). American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, IL,
June, 2017.
Ellen Lavoie Smith Last Revised 2/27/2020 39
46. a,b Knoerl, R., Smith, E. M. L., & Chornoby, Z. Estimating the Frequency, Severity, and Clustering
of SPADE Symptoms in Chronic Painful Chemotherapy Induced Peripheral Neuropathy (CIPN).
2018. (Abstract). American Pain Society Conference. Anaheim California, March 2018.
47. a,dDonohoe, C., Smith, E. L. (2018). Mental Health Predictors of Pain in Children and Adolescents
with Sickle Cell Disease (Abstract/Poster). Association of Pediatric hematology/Oncology Nurses
Annual Conference, Savannah, Georgia, September, 2018.
48. a,b,e Wagner, M. A., Smith, E. L., & Holden, J. E. (2018). Effectiveness of Duloxetine in Preventing
Painful CIPN (Abstract). Council for the Advancement of Nursing Science. September, 2018.
Washington, D.C. Accepted for podium presentation.
49. Wagner. M. A., Wickersham, K. E., Lassiter, C. B., Smith, E. M. L., Holden, E., & Dorsey, S. G.
(2018). Transcriptomic Profile of the Lateral Hypothalamus in the Development of Painful
Chemotherapy-induced Peripheral Neuropathy Before and After Cisplatin Treatment in Mice.
(Abstract/Poster). International Society of Nurses in Genetics. October, 2018. Orlando, Florida.
50. a,b,dKanzawa-Lee, G. A., Harte, S. E., Bridges, C. M., Brummett, C. M., Clauw, D. J., Williams, D.
A., Knoerl, R., Smith, E. M. L. (2017). Childhood Trauma and Cancer Treatment-Related Pain in
Breast Cancer Survivors. (Abstract/Podium). International Conference on Cancer Nursing, Anaheim,
CA, July 2017.
51. a,b.dKnoerl, R., Lee, D., Dudley, W. N., Smith, G., Bridges, C. M., Smith, E. M. L. (2017).
Examining the Impact of a Web-Based Cancer Care Planning System to Promote Patient Activation.
(Abstract/Podium). International Conference on Cancer Nursing, Anaheim, CA, July 2017.
52. a,bSmith, E. M. L., Yang, J. J., Bridges, C. M., Banerjee, T., Knoerl, R., Kanzawa-Lee, G., Lee, D.,
Haupt, R., Prasertsri, N., Alberti, P., Donohoe, C., Edwards, E., Loprinzi, C. (2017). Chemotherapy-
Induced Peripheral Neuropathy (CIPN) Measurement Using a Patient-Reported Outcome Measure.
(Abstract/Podium). International Conference on Cancer Nursing, Anaheim, CA, July 2017.
53. a,b,d,e Prasertrsi, N., & Smith, E. M. L. (2018). Feasibility, Usability and Acceptability of
Chemotherapy-Induced Pain and Neuropathy Mobile Application (mCIPN app) Educational
Teaching Approach for Nurses to Enhance Knowledge, Assessment, and Symptom Management
(Abstract). International Association for the Study of Pain. Boston, MA, September 2018.
54. a,b.eKnoerl, R., Smith, E. M. L., Han, A., Doe, A., Scott, K., & Berry, D. L. (2019). Characterizing
Patient-Clinician Chemotherapy-Induced Peripheral Neuropathy Assessment and Management
Communication Approaches. Abstract/Poster presented at the Oncology Nursing Society Congress,
Anaheim California, April, 2019.
55. a,b.d,eKanzawa-Lee, G., Krauss, J.; Larson, J., Ploutz-Snyder, R., Resnicow, K., & Smith, E. M. L.
(2019). Walking to Reduce Chemotherapy-Induced Peripheral Neuropathy: A Pilot Feasibility RCT
Abstract/Poster presented at the Oncology Nursing Society Congress, Anaheim California, April,
2019.
56. a,bMarcath, L. A., Kdwell, K. M., Smith, E. M. L., Vangipuram, K., Gersch, C., Burness, M. L.,
Griggs, J. J., Schott, A. F., Van Poznak, C., Hayes, D. F., Henry, N. L., Beutler, A. S., & Hertz, D.
L. EPHA genetics for prediction of paclitaxel-induced peripheral neuropathy sensitivity. (2019).
American Society of Clinical Oncology.
57. a,bJennaro, T. S., Smith, E. M. L., Vangipuram, K., Kidwell, K. M., Burness, M. L., Griggs, J. J.,
Van Poznak, C. H, Hayes, D. F., Henry, N. L., & Hertz,, D. L. (2019). Vitamin D insufficiency and
risk of paclitaxel-induced peripheral neuropathy. American Society of Clinical Oncology.
58. Woo, S., Veliz, P., Smith, E. L., Saint Arnault, D. M., Earl, A., Struble, L. M., & Larson, J. L.
(2020). Development and psychometric evaluation of the COPD-related Stigma Scale. Midwest
Nursing Research Society Annual Conference April 1-4, 2020. Schaumburg, IL.
Ellen Lavoie Smith Last Revised 2/27/2020 40
59. a,b,d,eKanzawa-Lee, G., Larson, J., Ploutz-Synder, R., Kraus, J., Resnicow, K., & Smith, E. M. L.
(2020). Moderate to Vigorous Physical Activity Feasibility in Chemotherapy-receiving
Gastrointestinal Cancer Suvivros. (Abstract). American College of Sports Medicine Annual
Meeting, May 26-30, 2020. San Francisco, CA.
International Abstract Presentations
1. a,bMaurer, L. H., Lewis, L., Rigas, J., Beaulieu, B., Nierenberg, D., Smith, E., Meyer, L., &
Hammond, S. (1997). The effect of paclitaxel scheduling on the pharmacokinetics of ifosfamide in
patients with lung cancer. (Abstract 151). Lung Cancer, 18(Suppl. 1), 41. Poster presentation at the
International Lung Cancer Society Conference, Dublin, Ireland.
2. a,bRigas, J., Leopold, K., Maurer L. H., Eaton W., Black, W., Smith, E., Meyer, L., & Hammond. S.
(1997). Daily paclitaxel and thoracic radiation for the treatment of stage II-IIIB NSCLC. (1997).
(Abstract 268). Lung Cancer, 18(Suppl. 1), 70. Poster presentation at the International Lung Cancer
Society Conference, Dublin, Ireland.
3. a,bMaurer, L. H., West, P., Eaton, W., Rigas, J., Leopold, K., Hammond, S., & Smith E. (1997).
Small cell lung cancer: 25 year experience from the Dartmouth Hitchcock medical center (DHMC):
How much has changed. (Abstract 44). Lung Cancer, 18(Suppl. 1), 14. Poster presentation at the
International Lung Cancer Society Conference, Dublin, Ireland.
4. a,bMeyer, L, Rigas, J., Hoopes, J., Leopold, K., Maurer, L. H., Eaton, W., Smith E., & Hammond S.
(1997). Fatigue and plasma cytokines in patients treated with combined modality therapy for non-
small cell lung cancer (NSCLC). (Abstract 792). Lung Cancer, 18(Suppl. 1), 204. Poster
presentation at the International Lung Cancer Society Conference, Dublin, Ireland.
5. a,bSmith, E. L., Hann, D., Ahles, T., Furstenberg, T., Mitchell, T., Meyer, L. Maurer, L. H., &
Rigas, J. (1997). Quality of life and dyspnea in lung cancer patients. (Abstract 795). Lung Cancer,
18(Suppl. 1), 205. Poster presentation at the International Lung Cancer Society Conference, Dublin,
Ireland.
6. a,bBakitas, M. A., Smith, E., Cohen, J., & Fadul, C. (2004, November 4-6). Measurement issues in
chemotherapy-induced peripheral neuropathy. Poster presentation at the International Conference
on the Mechanisms and Treatment of Neuropathic Pain, Bermuda.
7. Mulrooney, T., Disalvo, W., Gillock, K., Smith, E. L., Ludy, L., Schaal, A. D., Scott, M., & Meyer,
L. (2006). “Survive and Thrive: The APN Cares Clinic”: Development of an Advanced Practice
Nurse-Led Cancer Survivors Clinic in Rural Northern New England. Poster presentation, Italy.
8. a,bSmith, E. M. L., Lang, L., Ho, R., Wells, E. M., Hutchinson, R. J., Skiles, J., Chakraborty, A.,
Wei, C., Thomas, K., & Renbarger, J. (2014). Standing on Pins and Needles? Patterns and severity
of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia during
the first year of treatment. (Abstract Podium Presentation). International Society of Pediatric
Oncology Annual Conference, Toronto, Canada.
9. a,b,d Prasertrsi, N., Smith, E. M. L., Kaewmanee, C., Phanatchaya, K., & Munaudsa, B. (2016).
Chemotherapy-induced pain and neuropathy: A cross-sectional study in Thai Cancer Patients
(Abstract). International Association for the Study of Pain. Yokohma, Japan.
Papers and Abstracts Under Review.
1. a,bSalgado, T. M., Reed, H. L., Quinn, C., Syverson, J. G., Liu, J., Le-Rademacher, Farris, K. B.,
Vangipuram, K., Smith, E. M. L., Henry, N. L., & Hertz, D. L. (Under Review). Patient factors
associated with discrepancies between patient-reported and clinician-documented peripheral
neuropathy in women with breast cancer receiving paclitaxel. Cancer Nursing.
Ellen Lavoie Smith Last Revised 2/27/2020 41
2. a, bJennaro, T., Fanf, F., Kidwell, K. M., Smith, E. M. L., Vangipuram, K., Burness, M., Griggs, J.
J., Van Poznak, C., Hayes, D. F., Henry, N. L., & Hertz, D. L. (Under Review). Vitamin D
deficiency increases severity of paclitaxel-induced peripheral neuropathy. International Journal of
Cancer.
3. a,b,d,eSmith, E. M. L, Kuisell, C., Kanzawa-Lee, G., Cho, Y., R., Bridges, C. M., & Gilchrist, L. S.
(Under Review). Pediatric Assessment of Chemotherapy-Induced Peripheral Neuropathy Using a
Patient-Reported Outcome Measure: The P-CIN Measure. Abstract. Oncology Nursing Society
Annual Congress, April 29 – May 3, 2020. San Antonio, TX.
4. a,b,d,eSmith, E. M. L, Kuisell, C., Kanzawa-Lee, G., Cho, Y., R., Bridges, C. M., & Gilchrist, L. S.
(Under Review). Pediatric Assessment of Chemotherapy-Induced Peripheral Neuropathy Using a
Patient-Reported Outcome Measure: The P-CIN Measure. Abstract. University of Michigan
Research Day 2020.
5. a,b,d,eSmith, E. M. L, Kuisell, C., Kanzawa-Lee, G., Cho, Y., R., Bridges, C. M., & Gilchrist, L. S.
(Under Review). Pediatric Assessment of Chemotherapy-Induced Peripheral Neuropathy Using a
Patient-Reported Outcome Measure: The P-CIN Measure. Abstract. Peripheral Nerve Society
Annual Congress, June 27 – 30, 2020. Miami, FL.
7. a,eSmith, A., Umberfield, E., Granner, J., Harris, M., Shuman, C., Liestenfeltz, B., & Smith, E. M.
L. (Under Review). Development of the Collaboration for Innovation in Mentoring (CLIM) Survey:
A Measure of PhD Mentorship Quality in Nursing. Abstract. Midwest Nursing Research Society
Annual Conference April 1-4, 2020. Schaumburg, IL.
8. a,eSmith, A., Umberfield, E., Granner, J., Harris, M., Shuman, C., Liestenfeltz, B., & Smith, E. M.
L. (Under Review). Development of the Collaboration for Innovation in Mentoring (CLIM) Survey:
A Measure of PhD Mentorship Quality in Nursing. Abstract. University of Michigan Research Day
2020. Ann Arbor, MI.
9. a,b,d,eKanzawa-Lee, G., Larson, J., Ploutz-Synder, R., Kraus, J., Resnicow, K., & Smith, E. M. L.
(Under Review). Moderate to Vigorous Physical Activity Effect on Chemotherapy-Induced
Peripheral Neuropathy. (Abstract). American Society of Clinical Oncology Annual Meeting, May
29- June 2, 2020. Chicago, IL.
10. a,bLoprinzi, C.L., Lacchetti, C., Bleeker, J., Cavaletti, G., Chauhan, C., Hertz, D., Kelley, M. R.,
Lavino, A., Lustberg, M. B., Paice, J., Schneider, B. P., Smith, E. M. L., Smith, M. L., Smith, T.,
Terstriep, S., Wagner-Johnston, N., & Hershman. D. L. (Under Review). Prevention and
management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO
Clinical Practice Guideline Update. Journal of Clinical Oncology.
Papers and Abstracts in Preparation
1. a,b,d Prasertsri, N., Smith, E.M. L. The reliability and validity of the European Organization for
Research and Treatment of Cancer QLQ-CIPN20 Thai version.
2. a,b,e Wagner, M. A., Dorsey, S. G., Wickersham, K. E., Smith, E. L., Burke, D., & Holden, J. E. (In
Preparation). The Role of the Gene Expression in the Lateral Hypothalamus on the Development of
Allodynia After Cisplatin Treatment.
3. a,bAlbany, C., Dockter, T., Wolfe, E., LeRademacher, J., Wagner-Johnston, N., Einhorn, L., Hanna,
N., Lafky, J., Smith, E., Pachman, D., Staff, N., Loprinzi, C. L., & Costello, B. (In Preparation)
Cisplatin-associated neuropathy characteristics compared to other neurotoxic chemotherapy agents.
Supportive Care Cancer.
Ellen Lavoie Smith Last Revised 2/27/2020 42
4. a,b,d,eSmith, E. M. L., Donohoe, C., . . . (In Preparation). The Pediatric Chemotherapy-Induced
Neuropathy (P-CIN) patient-reported outcome measure: Results of preliminary psychometric testing.
5. aSmith, E. M. L., Weickel, R., Ploutz-Synder, R., Arslanian-Engoren, C., Lori, J., plus other, &
Thomas, L. (In Preparation). Using an Appreciative Inquiry Framework to Modernize Doctoral
Education in Nursing. Nursing Outlook.
6. a,eSmith, A. B., Shuman, C., Granner, J., Liestenfeltz, B., Harris, M., & Smith, E. M. L. (In
Preparation). Collaboration for Leadership and Innovation in Mentoring (CLIM): A tool for
measuring nursing PhD mentor/mentee relationship metrics.
top related